1.1 	A bill for an act
1.2 	relating to cannabis; modifying provisions regarding the sale of cannabinoids 
1.3 	derived from hemp; modifying medical cannabis provisions; modifying cannabis 
1.4 	business provisions; modifying the limits of delta-9 tetrahydrocannabinol in edible 
1.5 	cannabinoid products and lower-potency hemp edibles when intended to be 
1.6 	consumed as beverages;amending Minnesota Statutes 2024, sections 151.72, 
1.7 	subdivisions 3, 5a; 152.22, subdivisions 4, 7, 10, 13; 152.24; 152.25; 152.26; 
1.8 	152.261; 152.27, subdivisions 2, 7; 152.28, subdivisions 1, 3; 152.29, subdivisions 
1.9 	1, 2, 3a, 4; 152.31; 152.32, subdivision 2; 152.33, subdivisions 1a, 4; 152.35; 
1.10 	152.37; 342.01, subdivisions 9, 34, 47, 48, 50, 71, by adding subdivisions; 342.02, 
1.11 	subdivision 3; 342.09, subdivision 2; 342.10; 342.11; 342.12; 342.13; 342.14, 
1.12 	subdivisions 1, 3, 6; 342.151, subdivisions 2, 3; 342.17; 342.18, subdivision 2; 
1.13 	342.22, subdivision 3, by adding a subdivision; 342.28, subdivisions 1, 8; 342.29, 
1.14 	subdivisions 1, 7; 342.30, subdivision 1; 342.32, subdivisions 1, 4, 5; 342.33, 
1.15 	subdivision 1; 342.34, subdivision 5; 342.36, subdivision 6; 342.37, by adding 
1.16 	subdivisions; 342.39, subdivision 3; 342.43, subdivisions 1, 2, by adding a 
1.17 	subdivision; 342.44, subdivision 1; 342.45, subdivision 1, by adding subdivisions; 
1.18 	342.46, subdivisions 1, 3, 4, 5, 6, 7, 9, by adding subdivisions; 342.51, subdivision 
1.19 	2, by adding a subdivision; 342.515, subdivisions 1, 5, 7; 342.52, subdivision 9, 
1.20 	by adding a subdivision; 342.57; 342.59, subdivision 2; 342.61, subdivision 4; 
1.21 	342.62, subdivision 2; 342.63, subdivisions 2, 3, 5, 6; 342.64, subdivision 1; 342.66, 
1.22 	subdivision 6; proposing coding for new law in Minnesota Statutes, chapter 342; 
1.23 	repealing Minnesota Statutes 2024, sections 152.22, subdivision 2; 342.151, 
1.24 	subdivision 1; 342.36, subdivision 5.
1.25 	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

1.26 	ARTICLE 1
1.27 	MEDICAL CANNABIS

1.28 	Section 1. Minnesota Statutes 2024, section 152.22, subdivision 4, is amended to read:
1.29 		Subd. 4.Health care practitioner. "Health care practitioner" means a Minnesota licensed
1.30 	Minnesota-licensed doctor of medicine, a Minnesota licensed Minnesota-licensed physician 
1.31 	assistant acting within the scope of authorized practice, or a Minnesota licensed
2.1 	Minnesota-licensed advanced practice registered nurse who has an active license in good 
2.2 	standing and the primary responsibility for the care and treatment of the qualifying medical 
2.3 	condition of a person an individual diagnosed with a qualifying medical condition.

2.4 	Sec. 2. Minnesota Statutes 2024, section 152.22, subdivision 7, is amended to read:
2.5 		Subd. 7.Medical cannabis manufacturer. "Medical cannabis manufacturer" or 
2.6 	"manufacturer" means an entity registered by the commissioner office to cultivate, acquire, 
2.7 	manufacture, possess, prepare, transfer, transport, supply, or dispense medical cannabis, 
2.8 	delivery devices, or related supplies and educational materials.

2.9 	Sec. 3. Minnesota Statutes 2024, section 152.22, subdivision 10, is amended to read:
2.10 		Subd. 10.Patient registry number. "Patient registry number" means a unique 
2.11 	identification number assigned by the commissioner office to a patient enrolled in the registry 
2.12 	program.

2.13 	Sec. 4. Minnesota Statutes 2024, section 152.22, subdivision 13, is amended to read:
2.14 		Subd. 13.Registry verification. "Registry verification" means the verification provided 
2.15 	by the commissioner office that a patient is enrolled in the registry program and that includes 
2.16 	the patient's name, registry number, and, if applicable, the name of the patient's registered 
2.17 	designated caregiver or parent, legal guardian, or spouse.

2.18 	Sec. 5. Minnesota Statutes 2024, section 152.24, is amended to read:
2.19 	152.24 FEDERALLY APPROVED CLINICAL TRIALS.
2.20 	The commissioner office may prohibit enrollment of a patient in the registry program 
2.21 	if the patient is simultaneously enrolled in a federally approved clinical trial for the treatment 
2.22 	of a qualifying medical condition with medical cannabis. The commissioner office shall 
2.23 	provide information to all patients enrolled in the registry program on the existence of 
2.24 	federally approved clinical trials for the treatment of the patient's qualifying medical condition 
2.25 	with medical cannabis as an alternative to enrollment in the patient registry program.

2.26 	Sec. 6. Minnesota Statutes 2024, section 152.25, is amended to read:
2.27 	152.25 COMMISSIONER OFFICE DUTIES.
2.28 		Subdivision 1.Medical cannabis manufacturer registration. (a) The commissioner
2.29 	office shall register two in-state manufacturers for the production of all medical cannabis 
2.30 	within the state. A registration agreement between the commissioner office and a 
3.1 	manufacturer is nontransferable. The commissioner office shall register new manufacturers 
3.2 	or reregister the existing manufacturers by December 1 every two years, using the factors 
3.3 	described in this subdivision. The commissioner office shall accept applications after 
3.4 	December 1, 2014, if one of the manufacturers registered before December 1, 2014, ceases 
3.5 	to be registered as a manufacturer. The commissioner's office's determination that no 
3.6 	manufacturer exists to fulfill the duties under sections 152.22 to 152.37 is subject to judicial 
3.7 	review in Ramsey County District Court. Data submitted during the application process are 
3.8 	private data on individuals or nonpublic data as defined in section 13.02 until the 
3.9 	manufacturer is registered under this section. Data on a manufacturer that is registered are 
3.10 	public data, unless the data are trade secret or security information under section 13.37.
3.11 	(b) As a condition for registration, a manufacturer must agree to:
3.12 	(1) begin supplying medical cannabis to patients by July 1, 2015; and
3.13 	(2) comply with all requirements under sections 152.22 to 152.37.
3.14 	(c) The commissioner office shall consider the following factors when determining 
3.15 	which manufacturer to register:
3.16 	(1) the technical expertise of the manufacturer in cultivating medical cannabis and 
3.17 	converting the medical cannabis into an acceptable delivery method under section 152.22, 
3.18 	subdivision 6;
3.19 	(2) the qualifications of the manufacturer's employees;
3.20 	(3) the long-term financial stability of the manufacturer;
3.21 	(4) the ability to provide appropriate security measures on the premises of the 
3.22 	manufacturer;
3.23 	(5) whether the manufacturer has demonstrated an ability to meet the medical cannabis 
3.24 	production needs required by sections 152.22 to 152.37; and
3.25 	(6) the manufacturer's projection and ongoing assessment of fees on patients with a 
3.26 	qualifying medical condition.
3.27 	(d) If an officer, director, or controlling person of the manufacturer pleads or is found 
3.28 	guilty of intentionally diverting medical cannabis to a person other than allowed by law 
3.29 	under section 152.33, subdivision 1, the commissioner office may decide not to renew the 
3.30 	registration of the manufacturer, provided the violation occurred while the person was an 
3.31 	officer, director, or controlling person of the manufacturer.
4.1 	(e) The commissioner office shall require each medical cannabis manufacturer to contract 
4.2 	with an independent laboratory to test medical cannabis produced by the manufacturer. The 
4.3 	commissioner office shall approve the laboratory chosen by each manufacturer and require 
4.4 	that the laboratory report testing results to the manufacturer in a manner determined by the 
4.5 	commissioner office.
4.6 		Subd. 1a.Revocation or nonrenewal of a medical cannabis manufacturer 
4.7 	registration. If the commissioner office intends to revoke or not renew a registration issued 
4.8 	under this section, the commissioner office must first notify in writing the manufacturer 
4.9 	against whom the action is to be taken and provide the manufacturer with an opportunity 
4.10 	to request a hearing under the contested case provisions of chapter 14. If the manufacturer 
4.11 	does not request a hearing by notifying the commissioner office in writing within 20 days 
4.12 	after receipt of the notice of proposed action, the commissioner office may proceed with 
4.13 	the action without a hearing. For revocations, the registration of a manufacturer is considered 
4.14 	revoked on the date specified in the commissioner's office's written notice of revocation.
4.15 		Subd. 1b.Temporary suspension proceedings. The commissioner office may institute 
4.16 	proceedings to temporarily suspend the registration of a medical cannabis manufacturer for 
4.17 	a period of up to 90 days by notifying the manufacturer in writing if any action by an 
4.18 	employee, agent, officer, director, or controlling person of the manufacturer:
4.19 	(1) violates any of the requirements of sections 152.22 to 152.37 or the rules adopted 
4.20 	thereunder;
4.21 	(2) permits, aids, or abets the commission of any violation of state law at the 
4.22 	manufacturer's location for cultivation, harvesting, manufacturing, packaging, and processing 
4.23 	or at any site for distribution of medical cannabis;
4.24 	(3) performs any act contrary to the welfare of a registered patient or registered designated 
4.25 	caregiver; or
4.26 	(4) obtains, or attempts to obtain, a registration by fraudulent means or misrepresentation.
4.27 		Subd. 1c.Notice to patients. Upon the revocation or nonrenewal of a manufacturer's 
4.28 	registration under subdivision 1a or implementation of an enforcement action under 
4.29 	subdivision 1b that may affect the ability of a registered patient, registered designated 
4.30 	caregiver, or a registered patient's parent, legal guardian, or spouse to obtain medical cannabis 
4.31 	from the manufacturer subject to the enforcement action, the commissioner office shall 
4.32 	notify in writing each registered patient and the patient's registered designated caregiver or 
4.33 	registered patient's parent, legal guardian, or spouse about the outcome of the proceeding 
4.34 	and information regarding alternative registered manufacturers. This notice must be provided 
5.1 	two or more business days prior to the effective date of the revocation, nonrenewal, or other 
5.2 	enforcement action.
5.3 		Subd. 2.Range of compounds and dosages; report. The office shall review and publicly 
5.4 	report the existing medical and scientific literature regarding the range of recommended 
5.5 	dosages for each qualifying condition and the range of chemical compositions of any plant 
5.6 	of the genus cannabis that will likely be medically beneficial for each of the qualifying 
5.7 	medical conditions. The office shall make this information available to patients with 
5.8 	qualifying medical conditions beginning December 1, 2014, and update the information 
5.9 	every three years. The office may consult with the independent laboratory under contract 
5.10 	with the manufacturer or other experts in reporting the range of recommended dosages for 
5.11 	each qualifying medical condition, the range of chemical compositions that will likely be 
5.12 	medically beneficial, and any risks of noncannabis drug interactions. The office shall consult 
5.13 	with each manufacturer on an annual basis on medical cannabis offered by the manufacturer. 
5.14 	The list of medical cannabis offered by a manufacturer shall be published on the Office of 
5.15 	Cannabis Management website.
5.16 		Subd. 3.Deadlines.  The commissioner office shall adopt rules necessary for the 
5.17 	manufacturer to begin distribution of medical cannabis to patients under the registry program 
5.18 	by July 1, 2015, and have notice of proposed rules published in the State Register prior to 
5.19 	January 1, 2015.
5.20 		Subd. 4.Reports. (a) The commissioner office shall provide regular updates to the task 
5.21 	force on medical cannabis therapeutic research and to the chairs and ranking minority 
5.22 	members of the legislative committees with jurisdiction over health and human services, 
5.23 	public safety, judiciary, and civil law Cannabis Advisory Council under section 342.03
5.24 	regarding: (1) any changes in federal law or regulatory restrictions regarding the use of 
5.25 	medical cannabis or hemp; and (2) the market demand and supply in this state for products 
5.26 	made from hemp that can be used for medicinal purposes.
5.27 	(b) The commissioner office may submit medical research based on the data collected 
5.28 	under sections 152.22 to 152.37 to any federal agency with regulatory or enforcement 
5.29 	authority over medical cannabis to demonstrate the effectiveness of medical cannabis for 
5.30 	treating a qualifying medical condition.

6.1 	Sec. 7. Minnesota Statutes 2024, section 152.26, is amended to read:
6.2 	152.26 RULEMAKING.
6.3 	(a) The commissioner office may adopt rules to implement sections 152.22 to 152.37. 
6.4 	Rules for which notice is published in the State Register before January 1, 2015, may be 
6.5 	adopted using the process in section 14.389.
6.6 	(b) The commissioner office may adopt or amend rules, using the procedure in section 
6.7 	14.386, paragraph (a), to implement the addition of dried raw cannabis as an allowable form 
6.8 	of medical cannabis under section 152.22, subdivision 6, paragraph (a), clause (4). Section 
6.9 	14.386, paragraph (b), does not apply to these rules.

6.10 	Sec. 8. Minnesota Statutes 2024, section 152.261, is amended to read:
6.11 	152.261 RULES; ADVERSE INCIDENTS.
6.12 	(a) The commissioner of health office shall adopt rules to establish requirements for 
6.13 	reporting incidents when individuals who are not authorized to possess medical cannabis 
6.14 	under sections 152.22 to 152.37 are found in possession of medical cannabis. The rules 
6.15 	must identify professionals required to report, the information they are required to report, 
6.16 	and actions the reporter must take to secure the medical cannabis.
6.17 	(b) The commissioner of health office shall adopt rules to establish requirements for law 
6.18 	enforcement officials and health care professionals to report incidents involving an overdose 
6.19 	of medical cannabis to the commissioner of health office.
6.20 	(c) Rules must include the method by which the commissioner office will collect and 
6.21 	tabulate reports of unauthorized possession and overdose.

6.22 	Sec. 9. Minnesota Statutes 2024, section 152.27, subdivision 2, is amended to read:
6.23 		Subd. 2.Office duties. (a) The office shall:
6.24 	(1) give notice of the program to health care practitioners in the state who are eligible 
6.25 	to serve as health care practitioners and explain the purposes and requirements of the 
6.26 	program;
6.27 	(2) allow each health care practitioner who meets or agrees to meet the program's 
6.28 	requirements and who requests to participate, to be included in the registry program to 
6.29 	collect data for the patient registry;
6.30 	(3) provide explanatory information and assistance to each health care practitioner in 
6.31 	understanding the nature of therapeutic use of medical cannabis within program requirements;
7.1 	(4) create and provide a certification to be used by a health care practitioner for the 
7.2 	practitioner to certify whether a patient has been diagnosed with a qualifying medical 
7.3 	condition;
7.4 	(5) supervise the participation of the health care practitioner in conducting patient 
7.5 	treatment and health records reporting in a manner that ensures stringent security and 
7.6 	record-keeping requirements and that prevents the unauthorized release of private data on 
7.7 	individuals as defined by section 13.02;
7.8 	(6) develop safety criteria for patients with a qualifying medical condition as a 
7.9 	requirement of the patient's participation in the program, to prevent the patient from 
7.10 	undertaking any task under the influence of medical cannabis that would constitute negligence 
7.11 	or professional malpractice on the part of the patient; and
7.12 	(7) conduct research and studies based on data from health records submitted to the 
7.13 	registry program and submit reports on intermediate or final research results to the legislature 
7.14 	and major scientific journals. The office may contract with a third party to complete the 
7.15 	requirements of this clause. Any reports submitted must comply with section 152.28, 
7.16 	subdivision 2.
7.17 	(b) The office may add a delivery method under section 152.22, subdivision 6, upon a 
7.18 	petition from a member of the public or the Cannabis Advisory Council under section 342.03
7.19 	or as directed by law. If the office wishes to add a delivery method under section 152.22, 
7.20 	subdivision 6, the office must notify the chairs and ranking minority members of the 
7.21 	legislative policy committees having jurisdiction over health and public safety of the addition 
7.22 	and the reasons for its addition, including any written comments received by the office from 
7.23 	the public and any guidance received from the Cannabis Advisory Council under section 
7.24 	342.03, by January 15 of the year in which the office wishes to make the change. The change 
7.25 	shall be effective on August 1 of that year, unless the legislature by law provides otherwise.

7.26 	Sec. 10. Minnesota Statutes 2024, section 152.27, subdivision 7, is amended to read:
7.27 		Subd. 7.Notice requirements. Patients and registered designated caregivers shall notify 
7.28 	the commissioner office of any address or name change within 30 days of the change having 
7.29 	occurred. A patient or registered designated caregiver is subject to a $100 fine for failure 
7.30 	to notify the commissioner office of the change.

8.1 	Sec. 11. Minnesota Statutes 2024, section 152.28, subdivision 1, is amended to read:
8.2 		Subdivision 1.Health care practitioner duties. (a) Prior to a patient's enrollment in 
8.3 	the registry program, a health care practitioner shall:
8.4 	(1) determine, in the health care practitioner's medical judgment, whether a patient suffers 
8.5 	from a qualifying medical condition, and, if so determined, provide the patient with a 
8.6 	certification of that diagnosis;
8.7 	(2) advise patients, registered designated caregivers, and parents, legal guardians, or 
8.8 	spouses who are acting as caregivers of the existence of any nonprofit patient support groups 
8.9 	or organizations;
8.10 	(3) provide explanatory information from the office to patients with qualifying medical 
8.11 	conditions, including disclosure to all patients about the experimental nature of therapeutic 
8.12 	use of medical cannabis; the possible risks, benefits, and side effects of the proposed 
8.13 	treatment; the application and other materials from the office; and provide patients with the 
8.14 	Tennessen warning as required by section 13.04, subdivision 2; and
8.15 	(4) agree to continue treatment of the patient's qualifying medical condition and report 
8.16 	medical findings to the office.
8.17 	(b) Upon notification from the office of the patient's enrollment in the registry program, 
8.18 	the health care practitioner shall:
8.19 	(1) participate in the patient registry reporting system under the guidance and supervision 
8.20 	of the office;
8.21 	(2) report health records of the patient throughout the ongoing treatment of the patient 
8.22 	to the office in a manner determined by the commissioner office and in accordance with 
8.23 	subdivision 2;
8.24 	(3) determine, every three years, if the patient continues to suffer from a qualifying 
8.25 	medical condition and, if so, issue the patient a new certification of that diagnosis; and
8.26 	(4) otherwise comply with all requirements developed by the office.
8.27 	(c) A health care practitioner may utilize telehealth, as defined in section 62A.673, 
8.28 	subdivision 2, for certifications and recertifications.
8.29 	(d) Nothing in this section requires a health care practitioner to participate in the registry 
8.30 	program.

9.1 	Sec. 12. Minnesota Statutes 2024, section 152.28, subdivision 3, is amended to read:
9.2 		Subd. 3.Advertising restrictions. (a) A health care practitioner shall not publish or 
9.3 	cause to be published any advertisement that:
9.4 	(1) contains false or misleading statements about medical cannabis or about the medical 
9.5 	cannabis registry program;
9.6 	(2) uses colloquial terms to refer to medical cannabis, such as pot, weed, or grass;
9.7 	(3) states or implies the health care practitioner is endorsed by the Department of Health
9.8 	office or by the medical cannabis registry program;
9.9 	(4) includes images of cannabis in its plant or leaf form or of cannabis-smoking 
9.10 	paraphernalia; or
9.11 	(5) contains medical symbols that could reasonably be confused with symbols of 
9.12 	established medical associations or groups.
9.13 	(b) A health care practitioner found by the commissioner office to have violated this 
9.14 	subdivision is prohibited from certifying that patients have a qualifying medical condition 
9.15 	for purposes of patient participation in the registry program. The commissioner's office's
9.16 	decision that a health care practitioner has violated this subdivision is a final decision of 
9.17 	the commissioner office and is not subject to the contested case procedures in chapter 14.

9.18 	Sec. 13. Minnesota Statutes 2024, section 152.29, subdivision 1, is amended to read:
9.19 		Subdivision 1.Manufacturer; requirements. (a) A manufacturer may operate eight 
9.20 	distribution facilities, which may include the manufacturer's single location for cultivation, 
9.21 	harvesting, manufacturing, packaging, and processing but is not required to include that 
9.22 	location. The commissioner office shall designate the geographical service areas to be served 
9.23 	by each manufacturer based on geographical need throughout the state to improve patient 
9.24 	access. A manufacturer shall not have more than two distribution facilities in each 
9.25 	geographical service area assigned to the manufacturer by the commissioner office. A 
9.26 	manufacturer shall operate only one location where all cultivation, harvesting, manufacturing, 
9.27 	packaging, and processing of medical cannabis shall be conducted. This location may be 
9.28 	one of the manufacturer's distribution facility sites. The additional distribution facilities 
9.29 	may dispense medical cannabis and medical cannabis products but may not contain any 
9.30 	medical cannabis in a form other than those forms allowed under section 152.22, subdivision 
9.31 	6, and the manufacturer shall not conduct any cultivation, harvesting, manufacturing, 
9.32 	packaging, or processing at the other distribution facility sites. Any distribution facility 
9.33 	operated by the manufacturer is subject to all of the requirements applying to the 
10.1 	manufacturer under sections 152.22 to 152.37, including, but not limited to, security and 
10.2 	distribution requirements.
10.3 	(b) A manufacturer may acquire hemp grown in this state from a hemp grower, and may 
10.4 	acquire hemp products produced by a hemp processor. A manufacturer may manufacture 
10.5 	or process hemp and hemp products into an allowable form of medical cannabis under 
10.6 	section 152.22, subdivision 6. Hemp and hemp products acquired by a manufacturer under 
10.7 	this paragraph are subject to the same quality control program, security and testing 
10.8 	requirements, and other requirements that apply to medical cannabis under sections 152.22 
10.9 	to 152.37 and Minnesota Rules, chapter 4770.
10.10 	(c) A medical cannabis manufacturer shall contract with a laboratory approved by the 
10.11 	commissioner office, subject to any additional requirements set by the commissioner office, 
10.12 	for purposes of testing medical cannabis manufactured or hemp or hemp products acquired 
10.13 	by the medical cannabis manufacturer as to content, contamination, and consistency to 
10.14 	verify the medical cannabis meets the requirements of section 152.22, subdivision 6. The 
10.15 	cost of laboratory testing shall be paid by the manufacturer.
10.16 	(d) The operating documents of a manufacturer must include:
10.17 	(1) procedures for the oversight of the manufacturer and procedures to ensure accurate 
10.18 	record keeping;
10.19 	(2) procedures for the implementation of appropriate security measures to deter and 
10.20 	prevent the theft of medical cannabis and unauthorized entrance into areas containing medical 
10.21 	cannabis; and
10.22 	(3) procedures for the delivery and transportation of hemp between hemp growers and 
10.23 	manufacturers and for the delivery and transportation of hemp products between hemp 
10.24 	processors and manufacturers.
10.25 	(e) A manufacturer shall implement security requirements, including requirements for 
10.26 	the delivery and transportation of hemp and hemp products, protection of each location by 
10.27 	a fully operational security alarm system, facility access controls, perimeter intrusion 
10.28 	detection systems, and a personnel identification system.
10.29 	(f) A manufacturer shall not share office space with, refer patients to a health care 
10.30 	practitioner, or have any financial relationship with a health care practitioner.
10.31 	(g) A manufacturer shall not permit any person to consume medical cannabis on the 
10.32 	property of the manufacturer.
10.33 	(h) A manufacturer is subject to reasonable inspection by the commissioner office.
11.1 	(i) For purposes of sections 152.22 to 152.37, a medical cannabis manufacturer is not 
11.2 	subject to the Board of Pharmacy licensure or regulatory requirements under chapter 151.
11.3 	(j) A medical cannabis manufacturer may not employ any person who is under 21 years 
11.4 	of age or who has been convicted of a disqualifying felony offense. An employee of a 
11.5 	medical cannabis manufacturer must submit a completed criminal history records check 
11.6 	consent form, a full set of classifiable fingerprints, and the required fees for submission to 
11.7 	the Bureau of Criminal Apprehension before an employee may begin working with the 
11.8 	manufacturer. The bureau must conduct a Minnesota criminal history records check and 
11.9 	the superintendent is authorized to exchange the fingerprints with the Federal Bureau of 
11.10 	Investigation to obtain the applicant's national criminal history record information. The 
11.11 	bureau shall return the results of the Minnesota and federal criminal history records checks 
11.12 	to the commissioner office.
11.13 	(k) A manufacturer may not operate in any location, whether for distribution or 
11.14 	cultivation, harvesting, manufacturing, packaging, or processing, within 1,000 feet of a 
11.15 	public or private school existing before the date of the manufacturer's registration with the 
11.16 	commissioner office.
11.17 	(l) A manufacturer shall comply with reasonable restrictions set by the commissioner
11.18 	office relating to signage, marketing, display, and advertising of medical cannabis.
11.19 	(m) Before a manufacturer acquires hemp from a hemp grower or hemp products from 
11.20 	a hemp processor, the manufacturer must verify that the hemp grower or hemp processor 
11.21 	has a valid license issued by the commissioner of agriculture under chapter 18K.
11.22 	(n) Until a state-centralized, seed-to-sale system is implemented that can track a specific 
11.23 	medical cannabis plant from cultivation through testing and point of sale, the commissioner
11.24 	office shall conduct at least one unannounced inspection per year of each manufacturer that 
11.25 	includes inspection of:
11.26 	(1) business operations;
11.27 	(2) physical locations of the manufacturer's manufacturing facility and distribution 
11.28 	facilities;
11.29 	(3) financial information and inventory documentation, including laboratory testing 
11.30 	results; and
11.31 	(4) physical and electronic security alarm systems.

12.1 	Sec. 14. Minnesota Statutes 2024, section 152.29, subdivision 2, is amended to read:
12.2 		Subd. 2.Manufacturer; production. (a) A manufacturer of medical cannabis shall 
12.3 	provide a reliable and ongoing supply of all medical cannabis needed for the registry program 
12.4 	through cultivation by the manufacturer and through the purchase of hemp from hemp 
12.5 	growers.
12.6 	(b) All cultivation, harvesting, manufacturing, packaging, and processing of medical 
12.7 	cannabis must take place in an enclosed, locked facility at a physical address provided to 
12.8 	the commissioner office during the registration process.
12.9 	(c) A manufacturer must process and prepare any medical cannabis plant material or 
12.10 	hemp plant material into a form allowable under section 152.22, subdivision 6, prior to 
12.11 	distribution of any medical cannabis.

12.12 	Sec. 15. Minnesota Statutes 2024, section 152.29, subdivision 3a, is amended to read:
12.13 		Subd. 3a.Transportation of medical cannabis; transport staffing. (a) A medical 
12.14 	cannabis manufacturer may staff a transport motor vehicle with only one employee if the 
12.15 	medical cannabis manufacturer is transporting medical cannabis to either a certified 
12.16 	laboratory for the purpose of testing or a facility for the purpose of disposal. If the medical 
12.17 	cannabis manufacturer is transporting medical cannabis for any other purpose or destination, 
12.18 	the transport motor vehicle must be staffed with a minimum of two employees as required 
12.19 	by rules adopted by the commissioner office.
12.20 	(b) Notwithstanding paragraph (a), a medical cannabis manufacturer that is only 
12.21 	transporting hemp for any purpose may staff the transport motor vehicle with only one 
12.22 	employee.
12.23 	(c) A medical cannabis manufacturer may contract with a third party for armored car 
12.24 	services for deliveries of medical cannabis from its production facility to distribution 
12.25 	facilities. A medical cannabis manufacturer that contracts for armored car services remains 
12.26 	responsible for the transportation manifest and inventory tracking requirements in rules 
12.27 	adopted by the commissioner office.
12.28 	(d) Department of Health Office staff may transport medical cannabis for the purposes 
12.29 	of delivering medical cannabis and other samples to a laboratory for testing under rules 
12.30 	adopted by the commissioner office and in cases of special investigations when the 
12.31 	commissioner office has determined there is a potential threat to public health. The transport 
12.32 	motor vehicle must be staffed with a minimum of two Department of Health office
13.1 	employees. The employees must carry with them their Department of Health office
13.2 	identification card and a transport manifest.

13.3 	Sec. 16. Minnesota Statutes 2024, section 152.29, subdivision 4, is amended to read:
13.4 		Subd. 4.Report. (a) Each manufacturer shall report to the commissioner office on a 
13.5 	monthly basis the following information on each individual patient for the month prior to 
13.6 	the report:
13.7 	(1) the amount and dosages of medical cannabis distributed;
13.8 	(2) the chemical composition of the medical cannabis; and
13.9 	(3) the tracking number assigned to any medical cannabis distributed.
13.10 	(b) For transactions involving Tribal medical cannabis program patients, each 
13.11 	manufacturer shall report to the commissioner office on a weekly basis the following 
13.12 	information on each individual Tribal medical cannabis program patient for the week prior 
13.13 	to the report:
13.14 	(1) the name of the Tribal medical cannabis program in which the Tribal medical cannabis 
13.15 	program patient is enrolled;
13.16 	(2) the amount and dosages of medical cannabis distributed;
13.17 	(3) the chemical composition of the medical cannabis distributed; and
13.18 	(4) the tracking number assigned to the medical cannabis distributed.

13.19 	Sec. 17. Minnesota Statutes 2024, section 152.31, is amended to read:
13.20 	152.31 DATA PRACTICES.
13.21 	(a) Government data in patient files maintained by the commissioner office and the 
13.22 	health care practitioner, and data submitted to or by a medical cannabis manufacturer, are 
13.23 	private data on individuals, as defined in section 13.02, subdivision 12, or nonpublic data, 
13.24 	as defined in section 13.02, subdivision 9, but may be used for purposes of complying with 
13.25 	chapter 13 and complying with a request from the legislative auditor or the state auditor in 
13.26 	the performance of official duties. The provisions of section 13.05, subdivision 11, apply 
13.27 	to a registration agreement entered between the commissioner office and a medical cannabis 
13.28 	manufacturer under section 152.25.
14.1 	(b) Not public data maintained by the commissioner office may not be used for any 
14.2 	purpose not provided for in sections 152.22 to 152.37, and may not be combined or linked 
14.3 	in any manner with any other list, dataset, or database.
14.4 	(c) The commissioner office may execute data sharing arrangements with the 
14.5 	commissioner of agriculture to verify licensing, inspection, and compliance information 
14.6 	related to hemp growers and hemp processors under chapter 18K.

14.7 	Sec. 18. Minnesota Statutes 2024, section 152.32, subdivision 2, is amended to read:
14.8 		Subd. 2.Criminal and civil protections. (a) Subject to section 152.23, the following 
14.9 	are not violations under this chapter:
14.10 	(1) use or possession of medical cannabis or medical cannabis products by a patient 
14.11 	enrolled in the registry program; possession by a registered designated caregiver or the 
14.12 	parent, legal guardian, or spouse of a patient if the parent, legal guardian, or spouse is listed 
14.13 	on the registry verification; or use or possession of medical cannabis or medical cannabis 
14.14 	products by a Tribal medical cannabis program patient;
14.15 	(2) possession, dosage determination, or sale of medical cannabis or medical cannabis 
14.16 	products by a medical cannabis manufacturer, employees of a manufacturer, a Tribal medical 
14.17 	cannabis program manufacturer, employees of a Tribal medical cannabis program 
14.18 	manufacturer, a laboratory conducting testing on medical cannabis, or employees of the 
14.19 	laboratory; and
14.20 	(3) possession of medical cannabis or medical cannabis products by any person while 
14.21 	carrying out the duties required under sections 152.22 to 152.37.
14.22 	(b) Medical cannabis obtained and distributed pursuant to sections 152.22 to 152.37 and 
14.23 	associated property is not subject to forfeiture under sections 609.531 to 609.5316.
14.24 	(c) The commissioner office, members of a Tribal medical cannabis board, the 
14.25 	commissioner's office's or Tribal medical cannabis board's staff, the commissioner's office's
14.26 	or Tribal medical cannabis board's agents or contractors, and any health care practitioner 
14.27 	are not subject to any civil or disciplinary penalties by the Board of Medical Practice, the 
14.28 	Board of Nursing, or by any business, occupational, or professional licensing board or entity, 
14.29 	solely for participation in the registry program under sections 152.22 to 152.37 or in a Tribal 
14.30 	medical cannabis program. A pharmacist licensed under chapter 151 is not subject to any 
14.31 	civil or disciplinary penalties by the Board of Pharmacy when acting in accordance with 
14.32 	the provisions of sections 152.22 to 152.37. Nothing in this section affects a professional 
14.33 	licensing board from taking action in response to violations of any other section of law.
15.1 	(d) Notwithstanding any law to the contrary, the commissioner office, the governor of 
15.2 	Minnesota, or an employee of any state agency may not be held civilly or criminally liable 
15.3 	for any injury, loss of property, personal injury, or death caused by any act or omission 
15.4 	while acting within the scope of office or employment under sections 152.22 to 152.37.
15.5 	(e) Federal, state, and local law enforcement authorities are prohibited from accessing 
15.6 	the patient registry under sections 152.22 to 152.37 except when acting pursuant to a valid 
15.7 	search warrant.
15.8 	(f) Notwithstanding any law to the contrary, neither the commissioner office nor a public 
15.9 	employee may release data or information about an individual contained in any report, 
15.10 	document, or registry created under sections 152.22 to 152.37 or any information obtained 
15.11 	about a patient participating in the program, except as provided in sections 152.22 to 152.37.
15.12 	(g) No information contained in a report, document, or registry or obtained from a patient 
15.13 	under sections 152.22 to 152.37 or from a Tribal medical cannabis program patient may be 
15.14 	admitted as evidence in a criminal proceeding unless independently obtained or in connection 
15.15 	with a proceeding involving a violation of sections 152.22 to 152.37.
15.16 	(h) Notwithstanding section 13.09, any person who violates paragraph (e) or (f) is guilty 
15.17 	of a gross misdemeanor.
15.18 	(i) An attorney may not be subject to disciplinary action by the Minnesota Supreme 
15.19 	Court, a Tribal court, or the professional responsibility board for providing legal assistance 
15.20 	to prospective or registered manufacturers or others related to activity that is no longer 
15.21 	subject to criminal penalties under state law pursuant to sections 152.22 to 152.37, or for 
15.22 	providing legal assistance to a Tribal medical cannabis program or a Tribal medical cannabis 
15.23 	program manufacturer.
15.24 	(j) The following do not constitute probable cause or reasonable suspicion, and shall not 
15.25 	be used to support a search of the person or property of the person possessing or applying 
15.26 	for the registry verification or equivalent, or otherwise subject the person or property of the 
15.27 	person to inspection by any governmental agency:
15.28 	(1) possession of a registry verification or application for enrollment in the registry 
15.29 	program by a person entitled to possess a registry verification or apply for enrollment in 
15.30 	the registry program; or
15.31 	(2) possession of a verification or equivalent issued by a Tribal medical cannabis program 
15.32 	or application for enrollment in a Tribal medical cannabis program by a person entitled to 
15.33 	possess such a verification or application.

16.1 	Sec. 19. Minnesota Statutes 2024, section 152.33, subdivision 1a, is amended to read:
16.2 		Subd. 1a.Intentional diversion outside the state; penalties. (a) In addition to any other 
16.3 	applicable penalty in law, the commissioner office may levy a fine of $250,000 against a 
16.4 	manufacturer and may immediately initiate proceedings to revoke the manufacturer's 
16.5 	registration, using the procedure in section 152.25, if:
16.6 	(1) an officer, director, or controlling person of the manufacturer pleads or is found 
16.7 	guilty under subdivision 1 of intentionally transferring medical cannabis, while the person 
16.8 	was an officer, director, or controlling person of the manufacturer, to a person other than 
16.9 	allowed by law; and
16.10 	(2) in intentionally transferring medical cannabis to a person other than allowed by law, 
16.11 	the officer, director, or controlling person transported or directed the transport of medical 
16.12 	cannabis outside of Minnesota.
16.13 	(b) All fines collected under this subdivision shall be deposited in the state government 
16.14 	special revenue fund.

16.15 	Sec. 20. Minnesota Statutes 2024, section 152.33, subdivision 4, is amended to read:
16.16 		Subd. 4.Submission of false records; criminal penalty. A person who knowingly 
16.17 	submits false records or documentation required by the commissioner office to register as 
16.18 	a manufacturer of medical cannabis under sections 152.22 to 152.37 is guilty of a felony 
16.19 	and may be sentenced to imprisonment for not more than two years or by payment of a fine 
16.20 	of not more than $3,000, or both.

16.21 	Sec. 21. Minnesota Statutes 2024, section 152.35, is amended to read:
16.22 	152.35 FEES; DEPOSIT OF REVENUE.
16.23 	(a) The commissioner office shall collect an application fee of $20,000 from each entity 
16.24 	submitting an application for registration as a medical cannabis manufacturer. Revenue 
16.25 	from the fee shall be deposited in the state treasury and credited to the state government 
16.26 	special revenue fund.
16.27 	(b) The commissioner office shall establish and collect an annual fee from a medical 
16.28 	cannabis manufacturer equal to the cost of regulating and inspecting the manufacturer in 
16.29 	that year. Revenue from the fee amount shall be deposited in the state treasury and credited 
16.30 	to the state government special revenue fund.
17.1 	(c) A medical cannabis manufacturer may charge patients enrolled in the registry program 
17.2 	a reasonable fee for costs associated with the operations of the manufacturer. The 
17.3 	manufacturer may establish a sliding scale of patient fees based upon a patient's household 
17.4 	income and may accept private donations to reduce patient fees.

17.5 	Sec. 22. Minnesota Statutes 2024, section 152.37, is amended to read:
17.6 	152.37 FINANCIAL EXAMINATIONS; PRICING REVIEWS.
17.7 		Subdivision 1.Financial records. A medical cannabis manufacturer shall maintain 
17.8 	detailed financial records in a manner and format approved by the commissioner office, 
17.9 	and shall keep all records updated and accessible to the commissioner office when requested.
17.10 		Subd. 2.Certified annual audit. A medical cannabis manufacturer shall submit the 
17.11 	results of an annual certified financial audit to the commissioner office no later than May 
17.12 	1 of each year for the calendar year beginning January 2015. The annual audit shall be 
17.13 	conducted by an independent certified public accountant and the costs of the audit are the 
17.14 	responsibility of the medical cannabis manufacturer. Results of the audit shall be provided 
17.15 	to the medical cannabis manufacturer and the commissioner office. The commissioner office
17.16 	may also require another audit of the medical cannabis manufacturer by a certified public 
17.17 	accountant chosen by the commissioner office with the costs of the audit paid by the medical 
17.18 	cannabis manufacturer.
17.19 		Subd. 3.Power to examine. (a) The commissioner office or designee may examine the 
17.20 	business affairs and conditions of any medical cannabis manufacturer, including but not 
17.21 	limited to a review of the financing, budgets, revenues, sales, and pricing.
17.22 	(b) An examination may cover the medical cannabis manufacturer's business affairs, 
17.23 	practices, and conditions including but not limited to a review of the financing, budgets, 
17.24 	revenues, sales, and pricing. The commissioner office shall determine the nature and scope 
17.25 	of each examination and in doing so shall take into account all available relevant factors 
17.26 	concerning the financial and business affairs, practices, and conditions of the examinee. 
17.27 	The costs incurred by the department in conducting an examination shall be paid for by the 
17.28 	medical cannabis manufacturer.
17.29 	(c) When making an examination under this section, the commissioner office may retain 
17.30 	attorneys, appraisers, independent economists, independent certified public accountants, or 
17.31 	other professionals and specialists as designees. A certified public accountant retained by 
17.32 	the commissioner office may not be the same certified public accountant providing the 
17.33 	certified annual audit in subdivision 2.
18.1 	(d) The commissioner office shall make a report of an examination conducted under this 
18.2 	section and provide a copy to the medical cannabis manufacturer. The commissioner office
18.3 	shall then post a copy of the report on the department's website. All working papers, recorded 
18.4 	information, documents, and copies produced by, obtained by, or disclosed to the 
18.5 	commissioner office or any other person in the course of an examination, other than the 
18.6 	information contained in any commissioner office official report, made under this section 
18.7 	are private data on individuals or nonpublic data, as defined in section 13.02.

18.8 	Sec. 23. Minnesota Statutes 2024, section 342.01, is amended by adding a subdivision to 
18.9 	read:
18.10 		Subd. 54a.Medical cannabis paraphernalia. "Medical cannabis paraphernalia" means 
18.11 	a delivery device, related supply, or educational material used by a patient enrolled in the 
18.12 	registry program to administer medical cannabis and medical cannabinoid products.

18.13 	Sec. 24. Minnesota Statutes 2024, section 342.01, is amended by adding a subdivision to 
18.14 	read:
18.15 		Subd. 69c.Tribal medical cannabis board. "Tribal medical cannabis board" means an 
18.16 	agency established by a federally recognized Tribal government and authorized by the 
18.17 	Tribe's governing body to provide regulatory oversight and monitor compliance with a 
18.18 	Tribal medical cannabis program and applicable regulations.

18.19 	Sec. 25. Minnesota Statutes 2024, section 342.01, is amended by adding a subdivision to 
18.20 	read:
18.21 		Subd. 69d.Tribal medical cannabis program. "Tribal medical cannabis program" 
18.22 	means a program established by a federally recognized Tribal government within the 
18.23 	boundaries of Minnesota that involves the commercial production, processing, sale or 
18.24 	distribution, and possession of medical cannabis and medical cannabis products.

18.25 	Sec. 26. Minnesota Statutes 2024, section 342.01, is amended by adding a subdivision to 
18.26 	read:
18.27 		Subd. 69e.Tribal medical cannabis program patient. "Tribal medical cannabis program 
18.28 	patient" means a person who possesses a valid registration verification card or equivalent 
18.29 	document that is issued under the laws or regulations of a Tribal Nation within the boundaries 
18.30 	of Minnesota. A valid registration verification card must verify that the card holder is 
18.31 	enrolled in or authorized to participate in a Tribal medical cannabis program.

19.1 	Sec. 27. Minnesota Statutes 2024, section 342.01, subdivision 71, is amended to read:
19.2 		Subd. 71.Visiting patient. "Visiting patient" means an individual who is not a Minnesota 
19.3 	resident and who possesses a valid registration verification card or its equivalent that is 
19.4 	issued under the laws or regulations of another state, district, commonwealth, or territory 
19.5 	of the United States verifying that the individual is enrolled in or authorized to participate 
19.6 	in that jurisdiction's medical cannabis or medical marijuana program or in a Tribal medical 
19.7 	cannabis program.

19.8 	Sec. 28. Minnesota Statutes 2024, section 342.02, subdivision 3, is amended to read:
19.9 		Subd. 3.Medical cannabis program. (a) The powers and duties of the Department of 
19.10 	Health with respect to the medical cannabis program under Minnesota Statutes 2022, sections 
19.11 	152.22 to 152.37, are transferred to the Office of Cannabis Management under section 
19.12 	15.039.
19.13 	(b) The following protections shall apply to employees who are transferred from the 
19.14 	Department of Health to the Office of Cannabis Management:
19.15 	(1) the employment status and job classification of a transferred employee shall not be 
19.16 	altered as a result of the transfer;
19.17 	(2) transferred employees who were represented by an exclusive representative prior to 
19.18 	the transfer shall continue to be represented by the same exclusive representative after the 
19.19 	transfer;
19.20 	(3) the applicable collective bargaining agreements with exclusive representatives shall 
19.21 	continue in full force and effect for such transferred employees after the transfer;
19.22 	(4) the state must meet and negotiate with the exclusive representatives of the transferred 
19.23 	employees about any proposed changes affecting or relating to the transferred employees' 
19.24 	terms and conditions of employment to the extent such changes are not addressed in the 
19.25 	applicable collective bargaining agreement; and
19.26 	(5) for an employee in a temporary unclassified position transferred to the Office of 
19.27 	Cannabis Management, the total length of time that the employee has served in the 
19.28 	appointment shall include all time served in the appointment and the transferring agency 
19.29 	and the time served in the appointment at the Office of Cannabis Management. An employee 
19.30 	in a temporary unclassified position who was hired by a transferring agency through an 
19.31 	open competitive selection process in accordance with a policy enacted by Minnesota 
19.32 	Management and Budget shall be considered to have been hired through such process after 
19.33 	the transfer.
20.1 	(c) This subdivision is effective July 1, 2024.

20.2 	Sec. 29. Minnesota Statutes 2024, section 342.09, subdivision 2, is amended to read:
20.3 		Subd. 2.Home cultivation of cannabis for personal adult use. (a) Up to eight cannabis 
20.4 	plants, with no more than four being mature, flowering plants may be grown at a single 
20.5 	residence, including the curtilage or yard, without a license to cultivate cannabis issued 
20.6 	under this chapter provided that cultivation takes place at the primary residence of an 
20.7 	individual 21 years of age or older and in an enclosed, locked space that is not open to public 
20.8 	view.
20.9 	(b) Pursuant to section 342.52, subdivision 9, paragraph (d), a registered designated 
20.10 	caregiver may cultivate up to eight cannabis plants for not more than one patient household. 
20.11 	In addition to eight cannabis plants for one patient household, a registered designated 
20.12 	caregiver may cultivate up to eight cannabis plants for the caregiver's personal adult use of 
20.13 	cannabis. Of the 16 or fewer total cannabis plants being grown in the registered caregiver's 
20.14 	residence, no more than eight may be mature, flowering plants.

20.15 	Sec. 30. Minnesota Statutes 2024, section 342.51, subdivision 2, is amended to read:
20.16 		Subd. 2.Distribution requirements. (a) Prior to distribution of medical cannabis flower 
20.17 	or medical cannabinoid products to a person enrolled in the registry program, an employee 
20.18 	with a valid medical cannabis consultant certificate issued by the office or a licensed 
20.19 	pharmacist under chapter 151 of a cannabis business must:
20.20 	(1) review and confirm the patient's enrollment in the registry program;
20.21 	(2) verify that the person requesting the distribution of medical cannabis flower or 
20.22 	medical cannabinoid products is the patient, the patient's registered designated caregiver, 
20.23 	or the patient's parent, legal guardian, or spouse using the procedures established by the 
20.24 	office;
20.25 	(3) provide confirm that the patient had a consultation to the patient with (i) an employee 
20.26 	with a valid medical cannabis consultant certificate issued by the office; or (ii) an employee 
20.27 	who is a licensed pharmacist under chapter 151 to determine the proper medical cannabis 
20.28 	flower or medical cannabinoid product, dosage, and paraphernalia for the patient if required 
20.29 	under subdivision 3;
20.30 	(4) apply a patient-specific label on the medical cannabis flower or medical cannabinoid 
20.31 	product that includes recommended dosage requirements and other information as required 
20.32 	by the office; and
21.1 	(5) provide the patient with any other information required by the office.
21.2 	(b) A cannabis business with a medical cannabis retail endorsement may not deliver 
21.3 	medical cannabis flower or medical cannabinoid products to a person enrolled in the registry 
21.4 	program unless the cannabis business with a medical cannabis retail endorsement also holds 
21.5 	a cannabis delivery service license. The delivery of medical cannabis flower and medical 
21.6 	cannabinoid products are subject to the provisions of section 342.42.

21.7 	Sec. 31. Minnesota Statutes 2024, section 342.51, is amended by adding a subdivision to 
21.8 	read:
21.9 		Subd. 2a.Distribution to visiting patients. (a) A cannabis business with a medical 
21.10 	cannabis retail endorsement may distribute medical cannabis flower or medical cannabinoid 
21.11 	products to a visiting patient.
21.12 	(b) Before receiving a distribution of medical cannabis, a visiting patient must provide 
21.13 	to an employee of the cannabis business:
21.14 	(1) a valid medical cannabis registration verification card or equivalent document issued 
21.15 	under the laws and regulations of another state, district, commonwealth, Tribal Nation, or 
21.16 	territory that indicates that the visiting patient is authorized to use medical cannabis in the 
21.17 	issuing jurisdiction; and
21.18 	(2) a valid photographic identification card issued by the visiting patient's medical 
21.19 	cannabis program, a valid driver's license, or a valid state identification card.
21.20 	(c) Prior to the distribution of medical cannabis flower or medical cannabinoid products 
21.21 	to a visiting patient, an employee of a cannabis business must:
21.22 	(1) ensure that a patient-specific label has been applied to all medical cannabis flower 
21.23 	and medical cannabinoid products. The label must include the recommended dosage 
21.24 	requirements and other information required by the office; and
21.25 	(2) provide the patient with any other information required by the office.
21.26 	(d) For each transaction that involves a visiting patient, a cannabis business with a 
21.27 	medical cannabis retail endorsement must report to the office on a weekly basis:
21.28 	(1) the name of the visiting patient;
21.29 	(2) the name of the medical cannabis program in which the visiting patient is enrolled;
21.30 	(3) the amount and dosages of medical cannabis distributed;
21.31 	(4) the chemical composition of the medical cannabis distributed; and
22.1 	(5) the tracking number assigned to the medical cannabis that was distributed to the 
22.2 	visiting patient.
22.3 	(e) A cannabis business with a medical cannabis retail endorsement may distribute 
22.4 	medical cannabis flower and medical cannabinoid products to a visiting patient in a motor 
22.5 	vehicle if:
22.6 	(1) an employee of the cannabis business receives payment and distributes medical 
22.7 	cannabis flower and medical cannabinoid products in a designated zone that is as close as 
22.8 	feasible to the front door of the facility where the cannabis business is located;
22.9 	(2) the cannabis business with a medical cannabis retail endorsement ensures that the 
22.10 	receipt of payment and distribution of medical cannabis flower and medical cannabinoid 
22.11 	products are visually recorded by a closed-circuit television surveillance camera and provides 
22.12 	any other necessary security safeguards required by the office;
22.13 	(3) the cannabis business with a medical cannabis retail endorsement does not store 
22.14 	medical cannabis flower or medical cannabinoid products outside a restricted access area;
22.15 	(4) an employee of the cannabis business transports medical cannabis flower and medical 
22.16 	cannabinoid products from a restricted access area to the designated zone for distribution 
22.17 	to patients only after confirming that the visiting patient has arrived in the designated zone;
22.18 	(5) the payment for and distribution of medical cannabis flower and medical cannabinoid 
22.19 	products to a patient only occurs after meeting the requirements in paragraph (b);
22.20 	(6) immediately following the distribution of medical cannabis flower or medical 
22.21 	cannabinoid products to a patient, an employee of the cannabis business records the 
22.22 	transaction in the statewide monitoring system; and
22.23 	(7) immediately following the distribution of medical cannabis flower and medical 
22.24 	cannabinoid products, an employee of the cannabis business transports all payments received 
22.25 	into the facility where the cannabis business is located.

22.26 	Sec. 32. Minnesota Statutes 2024, section 342.515, subdivision 1, is amended to read:
22.27 		Subdivision 1.Authorized actions. (a) A person, cooperative, or business holding a 
22.28 	medical cannabis combination business license is prohibited from owning or operating any 
22.29 	other cannabis business or hemp business or holding an active registration agreement under 
22.30 	section 152.25, subdivision 1.
22.31 	(b) A person or business may hold only one medical cannabis combination business 
22.32 	license.
23.1 	(c) A medical cannabis combination business license entitles the license holder to perform 
23.2 	any or all of the following within the limits established by this section:
23.3 	(1) grow cannabis plants from seed or immature plant to mature plant and harvest 
23.4 	adult-use cannabis flower and medical cannabis flower from a mature plant;
23.5 	(2) make cannabis concentrate;
23.6 	(3) make hemp concentrate, including hemp concentrate with a delta-9 
23.7 	tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;
23.8 	(4) manufacture artificially derived cannabinoids;
23.9 	(5) manufacture medical cannabinoid products;
23.10 	(6) manufacture adult-use cannabis products, lower-potency hemp edibles, and 
23.11 	hemp-derived consumer products for public consumption;
23.12 	(7) purchase immature cannabis plants and seedlings and cannabis flower from a cannabis 
23.13 	microbusiness, a cannabis mezzobusiness, a cannabis manufacturer, a cannabis wholesaler, 
23.14 	or another medical cannabis combination business;
23.15 	(8) purchase hemp plant parts and propagules from an industrial hemp grower licensed 
23.16 	under chapter 18K;
23.17 	(9) purchase cannabis concentrate, hemp concentrate, and artificially derived cannabinoids 
23.18 	from a cannabis microbusiness, a cannabis mezzobusiness, a cannabis manufacturer, a 
23.19 	cannabis wholesaler, or another medical cannabis combination business;
23.20 	(10) purchase hemp concentrate from an industrial hemp processor licensed under chapter 
23.21 	18K;
23.22 	(11) manufacture, package, and label medical cannabis flower and medical cannabinoid 
23.23 	products for sale to cannabis businesses with a medical cannabis processor endorsement, 
23.24 	cannabis businesses with a medical cannabis retail endorsement, other medical cannabis 
23.25 	combination businesses, and persons in the registry program;
23.26 	(12) transport and deliver medical cannabis flower and medical cannabinoid products 
23.27 	to medical cannabis processors, medical cannabis retailers, other medical cannabis 
23.28 	combination businesses, patients enrolled in the registry program, registered designated 
23.29 	caregivers, and parents, legal guardians, and spouses of an enrolled patient;
23.30 	(12) (13) manufacture, package, and label adult-use cannabis flower, adult-use cannabis 
23.31 	products, lower-potency hemp edibles, and hemp-derived consumer products for sale to 
23.32 	customers and other cannabis businesses;
24.1 	(13) (14) sell medical cannabis flower and medical cannabinoid products to other cannabis 
24.2 	businesses with a medical endorsement, other medical cannabis combination businesses, 
24.3 	and patients enrolled in the registry program, registered designated caregivers, and parents, 
24.4 	legal guardians, and spouses of an enrolled patient;
24.5 	(14) (15) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use 
24.6 	cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and 
24.7 	other products authorized by law to other cannabis businesses and to customers; and
24.8 	(16) transport immature cannabis plants and seedlings, adult-use cannabis flower, 
24.9 	adult-use cannabis products, lower-potency hemp edibles, hemp-derived consumer products, 
24.10 	and other products authorized by law to other cannabis businesses;
24.11 	(17) sell and transport lower-potency hemp edibles to lower-potency hemp edible retailers 
24.12 	and lower-potency hemp edible wholesalers; and
24.13 	(15) (18) perform other actions approved by the office.
24.14 	(d) A medical cannabis combination business is not required to obtain a medical cannabis 
24.15 	endorsement to perform any actions authorized under this section.

24.16 	Sec. 33. Minnesota Statutes 2024, section 342.515, subdivision 5, is amended to read:
24.17 		Subd. 5.Failure to participate; suspension or revocation of license. (a) A medical 
24.18 	cannabis combination business must provide a reliable, ongoing supply of medical 
24.19 	cannabinoid products to the registry program. Providing a reliable, ongoing supply includes 
24.20 	but is not limited to:
24.21 	(1) making the three most commonly purchased medical cannabinoid products available 
24.22 	for wholesale; and
24.23 	(2) if there is a shortage of medical cannabis flower or medical cannabinoid products, 
24.24 	maintaining a stock of the three most commonly purchased medical cannabinoid products 
24.25 	at the retail location of the medical cannabis combination business.
24.26 	(b) The requirements under paragraph (a), clauses (1) and (2), do not apply to medical 
24.27 	cannabis flower.
24.28 	(c) A medical cannabis combination business must prioritize serving medical patients 
24.29 	and caregivers before serving adult-use consumers.
24.30 	(d) The office may suspend or revoke A medical cannabis combination business license 
24.31 	if the office determines that the business is no longer actively participating in the medical 
24.32 	cannabis market. The office may, by rule, establish minimum requirements related to 
25.1 	cannabis cultivation, manufacturing of medical cannabinoid products, retail sales of medical 
25.2 	cannabis flower and medical cannabinoid products, and other relevant criteria to demonstrate 
25.3 	active participation in the medical cannabis market.

25.4 	Sec. 34. Minnesota Statutes 2024, section 342.515, subdivision 7, is amended to read:
25.5 		Subd. 7.Transportation between facilities. A medical cannabis combination business 
25.6 	may transport immature cannabis plants and seedlings, cannabis flower, cannabis products, 
25.7 	artificially derived cannabinoids, hemp plant parts, hemp concentrate, lower-potency hemp 
25.8 	edibles, and hemp-derived consumer products between facilities operated by the medical 
25.9 	cannabis combination business if the medical cannabis combination business:
25.10 	(1) provides the office with the information described in section 342.35, subdivision 2; 
25.11 	and
25.12 	(2) complies with the requirements of section 342.36.

25.13 	Sec. 35. Minnesota Statutes 2024, section 342.52, is amended by adding a subdivision to 
25.14 	read:
25.15 		Subd. 7a.Allowable delivery methods. A patient in the registry program may receive 
25.16 	medical cannabis flower and medical cannabinoid products. The office may approve 
25.17 	additional delivery methods to expand the types of products that qualify as medical 
25.18 	cannabinoid products.

25.19 	Sec. 36. Minnesota Statutes 2024, section 342.52, subdivision 9, is amended to read:
25.20 		Subd. 9.Registered designated caregiver. (a) The office must register a designated 
25.21 	caregiver for a patient if the patient requires assistance in administering medical cannabis 
25.22 	flower or medical cannabinoid products; obtaining medical cannabis flower, medical 
25.23 	cannabinoid products, or medical cannabis paraphernalia from a cannabis business with a 
25.24 	medical cannabis retail endorsement; or cultivating cannabis plants as permitted by section 
25.25 	342.09, subdivision 2.
25.26 	(b) In order to serve as a designated caregiver, a person must:
25.27 	(1) be at least 18 years of age;
25.28 	(2) agree to only possess the patient's medical cannabis flower and medical cannabinoid 
25.29 	products for purposes of assisting the patient; and
26.1 	(3) agree that if the application is approved, the person will not serve as a registered 
26.2 	designated caregiver for more than six registered patients at one time. Patients who reside 
26.3 	in the same residence count as one patient.
26.4 	(c) Nothing in this section shall be construed to prevent a registered designated caregiver 
26.5 	from being enrolled in the registry program as a patient and possessing and administering 
26.6 	medical cannabis flower or medical cannabinoid products as a patient.
26.7 	(d) Notwithstanding any law to the contrary, a registered designated caregiver approved 
26.8 	to assist a patient enrolled in the registry program with obtaining medical cannabis flower 
26.9 	may cultivate cannabis plants on behalf of one patient. A registered designated caregiver 
26.10 	may grow up to eight cannabis plants for the patient household that the registered designated 
26.11 	caregiver is approved to assist with obtaining medical cannabis flower. If a patient enrolled 
26.12 	in the registry program directs the patient's registered designated caregiver to cultivate 
26.13 	cannabis plants on behalf of the patient, the patient must assign the patient's right to cultivate 
26.14 	cannabis plants to the registered designated caregiver and the notify the office. A patient 
26.15 	who assigns the patient's right to cultivate cannabis plants to a registered caregiver is 
26.16 	prohibited from cultivating cannabis plants for personal use. Nothing in this paragraph limits 
26.17 	the right of a registered designated caregiver cultivating cannabis plants on behalf of a 
26.18 	patient enrolled in the registry program to also cultivate cannabis plants for personal use 
26.19 	pursuant to section 342.09, subdivision 2.

26.20 	Sec. 37. Minnesota Statutes 2024, section 342.57, is amended to read:
26.21 	342.57 PROTECTIONS FOR REGISTRY PROGRAM PARTICIPANTS.
26.22 		Subdivision 1.Presumption. (a) There is a presumption that a patient or other person
26.23 	an individual enrolled in the registry program or a Tribal medical cannabis program patient 
26.24 	is engaged in the authorized use or possession of medical cannabis flower and medical 
26.25 	cannabinoid products.
26.26 	(b) This presumption may be rebutted by evidence that:
26.27 	(1) the use or possession of medical cannabis flower or medical cannabinoid products 
26.28 	by a patient or other person enrolled in the registry program was not for the purpose of 
26.29 	assisting with, treating, or alleviating the patient's qualifying medical condition or symptoms 
26.30 	associated with the patient's qualifying medical condition.; or
26.31 	(2) a Tribal medical cannabis program patient's use of medical cannabis was not for a 
26.32 	purpose authorized by the Tribal medical cannabis program.
27.1 		Subd. 2.Criminal and civil protections. (a) Subject to section 342.56, the following 
27.2 	are not violations of this chapter or chapter 152:
27.3 	(1) use or possession of medical cannabis flower, medical cannabinoid products, or 
27.4 	medical cannabis paraphernalia by a patient enrolled in the registry program or by, a visiting 
27.5 	patient, or a Tribal medical cannabis program patient to whom medical cannabis flower or 
27.6 	medical cannabinoid products are distributed under section 342.51, subdivision 5;
27.7 	(2) possession of medical cannabis flower, medical cannabinoid products, or medical 
27.8 	cannabis paraphernalia by a registered designated caregiver or a parent, legal guardian, or 
27.9 	spouse of a patient enrolled in the registry program; or
27.10 	(3) possession of medical cannabis flower, medical cannabinoid products, or medical 
27.11 	cannabis paraphernalia by any person while carrying out duties required under sections 
27.12 	342.51 to 342.60.
27.13 	(b) The Office of Cannabis Management, members of the Cannabis Advisory Council, 
27.14 	Office of Cannabis Management employees, agents or contractors of the Office of Cannabis 
27.15 	Management, members of a Tribal medical cannabis board, a Tribal medical cannabis board's 
27.16 	staff, a Tribal medical cannabis board's agents or contractors, and health care practitioners 
27.17 	participating in the registry program are not subject to any civil penalties or disciplinary 
27.18 	action by the Board of Medical Practice, the Board of Nursing, or any business, occupational, 
27.19 	or professional licensing board or entity solely for participating in the registry program or 
27.20 	a Tribal medical cannabis program either in a professional capacity or as a patient. A 
27.21 	pharmacist licensed under chapter 151 is not subject to any civil penalties or disciplinary 
27.22 	action by the Board of Pharmacy when acting in accordance with sections 342.51 to 342.60
27.23 	either in a professional capacity or as a patient. Nothing in this section prohibits a professional 
27.24 	licensing board from taking action in response to a violation of law.
27.25 	(c) Notwithstanding any law to the contrary, a Cannabis Advisory Council member, the 
27.26 	governor, or an employee of a state agency must not be held civilly or criminally liable for 
27.27 	any injury, loss of property, personal injury, or death caused by any act or omission while 
27.28 	acting within the scope of office or employment under sections 342.51 to 342.60.
27.29 	(d) Federal, state, and local law enforcement authorities are prohibited from accessing 
27.30 	the registry except when acting pursuant to a valid search warrant. Notwithstanding section 
27.31 	13.09, a violation of this paragraph is a gross misdemeanor.
27.32 	(e) Notwithstanding any law to the contrary, the office and employees of the office must 
27.33 	not release data or information about an individual contained in any report or document or 
27.34 	in the registry and must not release data or information obtained about a patient enrolled in 
28.1 	the registry program, except as provided in sections 342.51 to 342.60. Notwithstanding 
28.2 	section 13.09, a violation of this paragraph is a gross misdemeanor.
28.3 	(f) No information contained in a report or document, contained in the registry, or 
28.4 	obtained from a patient under sections 342.51 to 342.60or from a Tribal medical cannabis 
28.5 	program patient may be admitted as evidence in a criminal proceeding, unless:
28.6 	(1) the information is independently obtained; or
28.7 	(2) admission of the information is sought in a criminal proceeding involving a criminal 
28.8 	violation of sections 342.51 to 342.60.
28.9 	(g) Possession of a registry verification or an application for enrollment in the registry 
28.10 	program and possession of a verification or its equivalent issued by a Tribal medical cannabis 
28.11 	program or application for enrollment in a Tribal medical cannabis program by a person 
28.12 	entitled to possess the verification or application:
28.13 	(1) does not constitute probable cause or reasonable suspicion;
28.14 	(2) must not be used to support a search of the person or property of the person with a 
28.15 	registry verification or application to enroll in the registry program; and
28.16 	(3) must not subject the person or the property of the person to inspection by any 
28.17 	government agency.
28.18 	(h) A patient enrolled in the registry program or a Tribal medical cannabis program must 
28.19 	not be subject to any penalty or disciplinary action by an occupational or a professional 
28.20 	licensing board solely because:
28.21 	(1) the patient is enrolled in the registry program; or
28.22 	(2) the patient has a positive test for cannabis components or metabolites.
28.23 		Subd. 3.School enrollment; rental property. (a) No school may refuse to enroll or 
28.24 	otherwise penalize a patient or person enrolled in the registry program as a pupil solely 
28.25 	because the patient or person is enrolled in the registry program or a Tribal medical cannabis 
28.26 	program, unless failing to do so would violate federal law or regulations or cause the school 
28.27 	to lose a monetary or licensing-related benefit under federal law or regulations.
28.28 	(b) No landlord may refuse to lease to a patient or person enrolled in the registry program 
28.29 	or otherwise penalize a patient or person enrolled in the registry program solely because 
28.30 	the patient or person is enrolled in the registry program or a Tribal medical cannabis program, 
28.31 	unless failing to do so would violate federal law or regulations or cause the landlord to lose 
28.32 	a monetary or licensing-related benefit under federal law or regulations.
29.1 	(c) A school must not refuse to enroll a patient as a pupil solely because cannabis is a 
29.2 	controlled substance according to the Uniform Controlled Substances Act, United States 
29.3 	Code, title 21, section 812.
29.4 	(d) A school must not penalize a pupil who is a patient solely because cannabis is a 
29.5 	controlled substance according to the Uniform Controlled Substances Act, United States 
29.6 	Code, title 21, section 812.
29.7 	(e) A landlord must not refuse to lease a property to a patient solely because cannabis 
29.8 	is a controlled substance according to the Uniform Controlled Substances Act, United States 
29.9 	Code, title 21, section 812.
29.10 	(f) A landlord must not otherwise penalize a patient solely because cannabis is a controlled 
29.11 	substance according to the Uniform Controlled Substances Act, United States Code, title 
29.12 	21, section 812.
29.13 		Subd. 4.Medical care. For purposes of medical care, including organ transplants, a 
29.14 	patient's use of medical cannabis flower or medical cannabinoid products according to 
29.15 	sections 342.51 to 342.60, or a Tribal medical cannabis program patient's use of medical 
29.16 	cannabis as authorized by the Tribal medical cannabis program, is considered the equivalent 
29.17 	of the authorized use of a medication used at the discretion of a health care practitioner and 
29.18 	does not disqualify a patient from needed medical care.
29.19 		Subd. 5.Employment. (a) Unless a failure to do so would violate federal or state law 
29.20 	or regulations or cause an employer to lose a monetary or licensing-related benefit under 
29.21 	federal law or regulations, an employer may not discriminate against a person in hiring, 
29.22 	termination, or any term or condition of employment, or otherwise penalize a person, if the 
29.23 	discrimination is based on:
29.24 	(1) the person's status as a patient or person an individual enrolled in the registry program; 
29.25 	or
29.26 	(2) the person's status as a Tribal medical cannabis program patient; or
29.27 	(2) (3) a patient's positive drug test for cannabis components or metabolites, unless the 
29.28 	patient used, possessed, sold, transported, or was impaired by medical cannabis flower or 
29.29 	a medical cannabinoid product on work premises, during working hours, or while operating 
29.30 	an employer's machinery, vehicle, or equipment.
29.31 	(b) An employee who is a patient in the registry program or a Tribal medical cannabis 
29.32 	program and whose employer requires the employee to undergo drug testing according to 
29.33 	section 181.953 may present the employee's registry verification or verification of enrollment 
30.1 	in a Tribal medical cannabis program as part of the employee's explanation under section 
30.2 	181.953, subdivision 6.
30.3 		Subd. 5a.Notice. An employer, a school, or a landlord must provide written notice to 
30.4 	a patient at least 14 days before the employer, school, or landlord takes an action against 
30.5 	the patient that is prohibited under subdivision 3 or 5. The written notice must cite the 
30.6 	specific federal law or regulation that the employer, school, or landlord believes would be 
30.7 	violated if the employer, school, or landlord fails to take action. The notice must specify 
30.8 	what monetary or licensing-related benefit under federal law or regulations that the employer, 
30.9 	school, or landlord would lose if the employer, school, or landlord fails to take action.
30.10 		Subd. 6.Custody; visitation; parenting time. A person must not be denied custody of 
30.11 	a minor child or visitation rights or parenting time with a minor child based solely on the 
30.12 	person's status as a patient or person an individual enrolled in the registry program or on 
30.13 	the person's status as a Tribal medical cannabis program patient. There must be no 
30.14 	presumption of neglect or child endangerment for conduct allowed under sections 342.51
30.15 	to 342.60 or under a Tribal medical cannabis program, unless the person's behavior creates 
30.16 	an unreasonable danger to the safety of the minor as established by clear and convincing 
30.17 	evidence.
30.18 		Subd. 6a.Retaliation prohibited. A school, a landlord, a health care facility, or an 
30.19 	employer must not retaliate against a patient for asserting the patient's rights or seeking 
30.20 	remedies under this section or section 152.32.
30.21 		Subd. 7.Action for damages; injunctive relief. In addition to any other remedy provided 
30.22 	by law, a patient or person an individual enrolled in the registry program or a Tribal medical 
30.23 	cannabis program may bring an action for damages against any person who violates 
30.24 	subdivision 3, 4, or 5. A person who violates subdivision 3, 4, or 5 is liable to a patient or 
30.25 	person an individual enrolled in the registry program or a Tribal medical cannabis program 
30.26 	injured by the violation for the greater of the person's actual damages or a civil penalty of 
30.27 	$100 $1,000 and reasonable attorney fees. A patient may bring an action for injunctive relief 
30.28 	to prevent or end a violation of subdivisions 3 to 6a.
30.29 		Subd. 8.Sanctions restricted for those on parole, supervised release, or conditional 
30.30 	release. (a) This subdivision applies to an individual placed on parole, supervised release, 
30.31 	or conditional release.
30.32 	(b) The commissioner of corrections may not:
30.33 	(1) prohibit an individual from participating in the registry program or a Tribal medical 
30.34 	cannabis program as a condition of release; or
31.1 	(2) revoke an individual's parole, supervised release, or conditional release or otherwise 
31.2 	sanction an individual solely:
31.3 	(i) for participating in the registry program or a Tribal medical cannabis program; or
31.4 	(ii) for a positive drug test for cannabis components or metabolites.

31.5 	Sec. 38. Minnesota Statutes 2024, section 342.59, subdivision 2, is amended to read:
31.6 		Subd. 2.Allowable use; prohibited use. Data specified in subdivision 1 may be used 
31.7 	to comply with chapter 13, to comply with a request from the legislative auditor or the state 
31.8 	auditor in the performance of official duties, and for purposes specified in sections 342.47
31.9 	342.51 to 342.60. Data specified in subdivision 1 and maintained by the Office of Cannabis 
31.10 	Management or Division of Medical Cannabis must not be used for any purpose not specified 
31.11 	in sections 342.47342.51 to 342.60 and must not be combined or linked in any manner 
31.12 	with any other list, dataset, or database. Data specified in subdivision 1 must not be shared 
31.13 	with any federal agency, federal department, or federal entity unless specifically ordered 
31.14 	to do so by a state or federal court.

31.15 	Sec. 39. REPEALER.
 31.16 	Minnesota Statutes 2024, sections 152.22, subdivision 2; and 342.151, subdivision 1,
31.17 	are repealed.

31.18 	ARTICLE 2
31.19 	CANNABIS BUSINESS LICENSING AND OPERATIONS

31.20 	Section 1. Minnesota Statutes 2024, section 342.12, is amended to read:
31.21 	342.12 LICENSES; TRANSFERS; ADJUSTMENTS.
31.22 	(a) Licenses issued under this chapter that are available to all applicants pursuant to 
31.23 	section 342.14, subdivision 1b, paragraph (c), may be freely transferred subject to the prior 
31.24 	written approval of the office unless the license holder has not received a final site inspection 
31.25 	or the license holder is a social equity applicant.
31.26 	(b) Licenses issued as social equity licenses pursuant to either section 342.14, subdivision 
31.27 	1b, paragraph (b), or section 342.175, paragraph (b), may only be transferred to another 
31.28 	social equity applicant for three years after the date on which the office issues the license. 
31.29 	Three years after the date of issuance, a license holder may transfer a license to any entity. 
31.30 	Transfer of a license that was issued as a social equity license must be reviewed by the 
31.31 	Division of Social Equity and is subject to the prior written approval of the office.
32.1 	(c) Preliminary license preapproval approval issued pursuant to section 342.125342.14, 
32.2 	subdivision 5, may not be transferred.
32.3 	(d) A new license must be obtained when:
32.4 	(1) the form of the licensee's legal business structure converts or changes to a different 
32.5 	type of legal business structure; or
32.6 	(2) the licensee dissolves; consolidates; reorganizes; undergoes bankruptcy, insolvency, 
32.7 	or receivership proceedings; merges with another legal organization; or assigns all or 
32.8 	substantially all of its assets for the benefit of creditors.
32.9 	(e) Licenses must be renewed annually.
32.10 	(f) License holders may petition the office to adjust the tier of a license issued within a 
32.11 	license category if the license holder meets all applicable requirements.
32.12 	(g) The office by rule may permit the relocation of a licensed cannabis business; permit 
32.13 	the relocation of an approved operational location, including a cultivation, manufacturing, 
32.14 	processing, or retail location; adopt requirements for the submission of a license relocation 
32.15 	application; establish standards for the approval of a relocation application; and charge a 
32.16 	fee not to exceed $250 for reviewing and processing applications. Relocation of a licensed 
32.17 	premises pursuant to this paragraph does not extend or otherwise modify the license term 
32.18 	of the license subject to relocation.

32.19 	Sec. 2. Minnesota Statutes 2024, section 342.14, subdivision 1, is amended to read:
32.20 		Subdivision 1.Application; contents. (a) The office shall establish procedures for the 
32.21 	processing of cannabis licenses issued under this chapter. At a minimum, any application 
32.22 	to obtain or renew a cannabis license shall include the following information, if applicable:
32.23 	(1) the name, address, and date of birth of the applicant;
32.24 	(2) the disclosure of ownership and control required under paragraph (b);
32.25 	(3) the disclosure of whether the applicant or, if the applicant is a business, any officer, 
32.26 	director, manager, and general partner of the business has ever filed for bankruptcy;
32.27 	(4) the address and legal property description of the business, if applicable, except an 
32.28 	applicant is not required to secure a physical premises for the business at the time of 
32.29 	application;
33.1 	(5) a general description of the location or locations that the applicant plans to operate, 
33.2 	including the planned square feet of space for cultivation, wholesaling, and retailing, as 
33.3 	applicable;
33.4 	(6) a copy of the security plan, including security monitoring, security equipment, and 
33.5 	facility maps if applicable, except an applicant is not required to secure a physical premises 
33.6 	for the business at the time of application;
33.7 	(7) proof of trade name registration;
33.8 	(8) a copy of the applicant's business plan showing the expected size of the business; 
33.9 	anticipated growth; the methods of record keeping; the knowledge and experience of the 
33.10 	applicant and any officer, director, manager, and general partner of the business; the 
33.11 	environmental plan; and other relevant financial and operational components;
33.12 	(9) standard operating procedures for:
33.13 	(i) quality assurance;
33.14 	(ii) inventory control, storage, and diversion prevention; and
33.15 	(iii) accounting and tax compliance;
33.16 	(10) an attestation signed by a bona fide labor organization stating that the applicant has 
33.17 	entered into a labor peace agreement;
33.18 	(11) a description of any training and education that the applicant will provide to 
33.19 	employees of the business;
33.20 	(12) a disclosure of any violation of a license agreement or a federal, state, or local law 
33.21 	or regulation committed by the applicant or any true party of interest in the applicant's 
33.22 	business that is relevant to business and working conditions;
33.23 	(13) certification that the applicant will comply with the requirements of this chapter;
33.24 	(14) identification of one or more controlling persons or managerial employees as agents 
33.25 	who shall be responsible for dealing with the office on all matters;
33.26 	(15) a statement that the applicant agrees to respond to the office's supplemental requests 
33.27 	for information; and
33.28 	(16) a release of information for the applicant and every true party of interest in the 
33.29 	applicant's business license for the office to perform the background checks required under 
33.30 	section 342.15.;
33.31 	(17) proof that the applicant is a social equity applicant; and
34.1 	(18) an attestation that the applicant's business policies governing business operations 
34.2 	comply with this chapter.
34.3 	(b) An applicant must file and update as necessary a disclosure of ownership and control 
34.4 	identifying any true party of interest as defined in section 342.185, subdivision 1, paragraph 
34.5 	(g). The office shall establish the contents of the disclosure. Except as provided in paragraph 
34.6 	(f) (d), the disclosure shall, at a minimum, include the following:
34.7 	(1) the management structure, ownership, and control of the applicant or license holder, 
34.8 	including the name of each cooperative member, officer, director, manager, general partner, 
34.9 	or business entity; the office or position held by each person; each person's percentage 
34.10 	ownership interest, if any; and, if the business has a parent company, the name of each 
34.11 	owner, board member, and officer of the parent company and the owner's, board member's, 
34.12 	or officer's percentage ownership interest in the parent company and the cannabis business;
34.13 	(2) a statement from the applicant and, if the applicant is a business, from every officer, 
34.14 	director, manager, and general partner of the business, indicating whether that person has 
34.15 	previously held, or currently holds, an ownership interest in a cannabis business in Minnesota, 
34.16 	any other state or territory of the United States, or any other country;
34.17 	(3) if the applicant is a corporation, copies of the applicant's articles of incorporation 
34.18 	and bylaws and any amendments to the applicant's articles of incorporation or bylaws;
34.19 	(4) copies of any partnership agreement, operating agreement, or shareholder agreement;
34.20 	(5) copies of any promissory notes, security instruments, or other similar agreements;
34.21 	(6) an explanation detailing the funding sources used to finance the business;
34.22 	(7) a list of operating and investment accounts for the business, including any applicable 
34.23 	financial institution and account number; and
34.24 	(8) a list of each outstanding loan and financial obligation obtained for use in the business, 
34.25 	including the loan amount, loan terms, and name and address of the creditor.
34.26 	(c) An application may include:
34.27 	(1) proof that the applicant is a social equity applicant;
34.28 	(2) a description of the training and education that will be provided to any employee; 
34.29 	or
34.30 	(3) a copy of business policies governing operations to ensure compliance with this 
34.31 	chapter.
35.1 	(d) (c) Commitments made by an applicant in its application, including but not limited 
35.2 	to the maintenance of a labor peace agreement, shall be an ongoing material condition of 
35.3 	maintaining and renewing the license.
35.4 	(e) An application on behalf of a corporation or association shall be signed by at least 
35.5 	two officers or managing agents of that entity.
35.6 	(f) (d) The office may establish exceptions to the disclosures required under paragraph 
35.7 	(b) for members of a cooperative who hold less than a five percent ownership interest in 
35.8 	the cooperative.

35.9 	Sec. 3. Minnesota Statutes 2024, section 342.14, subdivision 3, is amended to read:
35.10 		Subd. 3.Review. (a) After an applicant submits an application that contains all required 
35.11 	information and pays the applicable licensing application fee, the office must review the 
35.12 	application.
35.13 	(b) The office may deny an application if:
35.14 	(1) the application is incomplete;
35.15 	(2) the application contains a materially false statement about the applicant or omits 
35.16 	information required under subdivision 1;
35.17 	(3) the applicant does not meet the qualifications under section 342.16;
35.18 	(4) the applicant is prohibited from holding the license under section 342.18, subdivision 
35.19 	2;
35.20 	(5) the application does not meet the minimum requirements under section 342.18, 
35.21 	subdivision 3;
35.22 	(6) the applicant fails to pay the applicable application fee;
35.23 	(7) the application was not submitted by the application deadline;
35.24 	(8) the applicant submitted more than one application for a license type; or
35.25 	(9) the office determines that the applicant would be prohibited from holding a license 
35.26 	for any other reason.
35.27 	(c) If the office denies an application, the office must notify the applicant of the denial 
35.28 	and the basis for the denial.
35.29 	(d) The office may request additional information from any applicant if the office 
35.30 	determines that the information is necessary to review or process the application. If the 
36.1 	applicant does not provide the additional requested information within 14 calendar days of 
36.2 	the office's request for information, the office may deny the application.
36.3 	(e) An applicant whose application is not denied under this subdivision is a qualified 
36.4 	applicant.

36.5 	Sec. 4. Minnesota Statutes 2024, section 342.14, subdivision 6, is amended to read:
36.6 		Subd. 6.Completed application; final authorization; issuance of license. (a) Within 
36.7 	18 months of receiving notice of preliminary license approval, an applicant must provide:
36.8 	(1) the address and legal property description of the location where the business will 
36.9 	operate;
36.10 	(2) the name of the local unit of government where the business will be located; and
36.11 	(3) if applicable, an updated description of the location where the business will operate, 
36.12 	an updated security plan, and any other additional information required by the office.
36.13 	(b) Upon receipt of the information required under paragraph (a) from an applicant that 
36.14 	has received preliminary license approval, the office must:
36.15 	(1) forward a copy of the application to the local unit of government in which the business 
36.16 	operates or intends to operate with a form for certification as to whether a proposed cannabis 
36.17 	business complies with local zoning ordinances and, if applicable, whether the proposed 
36.18 	business complies with the state fire code and building code;
36.19 	(2) schedule a site inspection; and
36.20 	(3) require the applicant to pay the applicable license fee.
36.21 	(c) The office may deny final authorization if:
36.22 	(1) an applicant fails to submit any required information;
36.23 	(2) the applicant submits a materially false statement about the applicant or fails to 
36.24 	provide any required information;
36.25 	(3) the office confirms that the cannabis business for which the office granted a 
36.26 	preliminary license preapproval approval does not meet local zoning and land use laws;
36.27 	(4) the applicant fails to pay the applicable license fee; or
36.28 	(5) the office determines that the applicant is disqualified from holding the license or 
36.29 	would operate in violation of the provisions of this chapter.
37.1 	(d) Within 90 days of receiving the information required under paragraph (a) and the 
37.2 	results of any required background check, the office shall grant final authorization and issue 
37.3 	the appropriate license or send the applicant a notice of rejection setting forth specific 
37.4 	reasons that the office did not approve the application.

37.5 	Sec. 5. Minnesota Statutes 2024, section 342.151, subdivision 2, is amended to read:
37.6 		Subd. 2.Criminal history check. A license holder cannabis business may employ or 
37.7 	contract with as many unlicensed individuals as may be necessary, provided that the license 
37.8 	holder cannabis business is at all times accountable for the good conduct of every individual 
37.9 	employed by or contracted with the license holder cannabis business. Before hiring an 
37.10 	individual as a cannabis worker, the license holder cannabis business must submit to the 
37.11 	Bureau of Criminal Apprehension the individual's full set of fingerprints and written consent 
37.12 	for the bureau to conduct a state and national criminal history check. The bureau may 
37.13 	exchange an individual's fingerprints with the Federal Bureau of Investigation. The Bureau 
37.14 	of Criminal Apprehension must determine whether the individual is qualified to be employed 
37.15 	as a cannabis worker and must notify the license holdercannabis business of the bureau's 
37.16 	determination. The license holder cannabis business must not employ an individual who is 
37.17 	disqualified from being employed as a cannabis worker.

37.18 	Sec. 6. Minnesota Statutes 2024, section 342.151, subdivision 3, is amended to read:
37.19 		Subd. 3.Disqualification. (a) A license holder cannabis business must not employ an 
37.20 	individual as a cannabis worker if the individual has been convicted of any of the following 
37.21 	crimes that would constitute a felony:
37.22 	(1) human trafficking;
37.23 	(2) noncannabis controlled substance crimes in the first or second degree;
37.24 	(3) labor trafficking;
37.25 	(4) fraud;
37.26 	(5) embezzlement;
37.27 	(6) extortion;
37.28 	(7) money laundering; or
37.29 	(8) insider trading;
37.30 	if committed in this state or any other jurisdiction for which a full pardon or similar relief 
37.31 	has not been granted.
38.1 	(b) A license holder cannabis business must not employ an individual as a cannabis 
38.2 	worker if the individual made any false statement in an application for employment.

38.3 	Sec. 7. Minnesota Statutes 2024, section 342.17, is amended to read:
38.4 	342.17 SOCIAL EQUITY APPLICANTS.
38.5 	(a) An applicant qualifies as a social equity applicant if the applicant:
38.6 	(1) was found delinquent for, received a stay of adjudication for, or was convicted of 
38.7 	an offense involving the possession or sale of cannabis or marijuana prior to May 1, 2023;
38.8 	(2) had a parent, guardian, child, spouse, or dependent who was convicted of an offense 
38.9 	involving the possession or sale of cannabis or marijuana prior to May 1, 2023;
38.10 	(3) was a dependent of an individual who was convicted of an offense involving the 
38.11 	possession or sale of cannabis or marijuana prior to May 1, 2023;
38.12 	(4) is a military veteran, including a service-disabled veteran, current or former member 
38.13 	of the national guard;
38.14 	(5) is a military veteran or current or former member of the national guard who lost 
38.15 	honorable status due to an offense involving the possession or sale of cannabis or marijuana;
38.16 	(6) has been a resident for the last five years of one or more subareas, such as census 
38.17 	tracts or neighborhoods:
38.18 	(i) that experienced a disproportionately large amount of cannabis enforcement as 
38.19 	determined by the study conducted by the office pursuant to section 342.04, paragraph (b), 
38.20 	or another report based on federal or state data on arrests or convictions;
38.21 	(ii) where the poverty rate was 20 percent or more;
38.22 	(iii) where the median family income did not exceed 80 percent of the statewide median 
38.23 	family income or, if in a metropolitan area, did not exceed the greater of 80 percent of the 
38.24 	statewide median family income or 80 percent of the median family income for that 
38.25 	metropolitan area;
38.26 	(iv) where at least 20 percent of the households receive assistance through the 
38.27 	Supplemental Nutrition Assistance Program; or
38.28 	(v) where the population has a high level of vulnerability according to the Centers for 
38.29 	Disease Control and Prevention and Agency for Toxic Substances and Disease Registry 
38.30 	(CDC/ATSDR) Social Vulnerability Index; or
39.1 	(7) has participated in the business operation of a farm for at least three years and 
39.2 	currently provides the majority of the day-to-day physical labor and management of a farm 
39.3 	that had gross farm sales of at least $5,000 but not more than $100,000 in the previous year.
39.4 	(b) The qualifications described in paragraph (a) apply to each individual applicant or, 
39.5 	in the case of a business entity, apply to at least 65 percent of the controlling ownership of 
39.6 	the business entity.

39.7 	Sec. 8. Minnesota Statutes 2024, section 342.22, subdivision 3, is amended to read:
39.8 		Subd. 3.Issuance of registration. (a) A local unit of government shall issue a retail 
39.9 	registration to a cannabis microbusiness with a retail operations endorsement, cannabis 
39.10 	mezzobusiness with a retail operations endorsement, cannabis retailer, medical cannabis 
39.11 	combination business operating a retail location, or lower-potency hemp edible retailer that:
39.12 	(1) has a valid license or preliminary license preapproval approval issued by the office;
39.13 	(2) has paid the registration fee or renewal fee pursuant to subdivision 2;
39.14 	(3) is found to be in compliance with the requirements of this chapter at any preliminary 
39.15 	compliance check that the local unit of government performs; and
39.16 	(4) if applicable, is current on all property taxes and assessments at the location where 
39.17 	the retail establishment is located.
39.18 	(b) Before issuing a retail registration, the local unit of government may conduct a 
39.19 	preliminary compliance check to ensure that the cannabis business or hemp business is in 
39.20 	compliance with any applicable local ordinance established pursuant to section 342.13.
39.21 	(c) A local unit of government shall renew the retail registration of a cannabis business 
39.22 	or hemp business when the office renews the license of the cannabis business or hemp 
39.23 	business.
39.24 	(d) A retail registration issued under this section may not be transferred.

39.25 	Sec. 9. Minnesota Statutes 2024, section 342.28, subdivision 1, is amended to read:
39.26 		Subdivision 1.Authorized actions. A cannabis microbusiness license, consistent with 
39.27 	the specific license endorsement or endorsements, entitles the license holder to perform any 
39.28 	or all of the following within the limits established by this section:
39.29 	(1) grow cannabis plants from seed or immature plant to mature plant and harvest 
39.30 	cannabis flower from a mature plant;
40.1 	(2) make cannabis concentrate;
40.2 	(3) make hemp concentrate, including hemp concentrate with a delta-9 
40.3 	tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;
40.4 	(4) manufacture artificially derived cannabinoids;
40.5 	(5) manufacture adult-use cannabis products, lower-potency hemp edibles, and 
40.6 	hemp-derived consumer products for public consumption;
40.7 	(6) purchase immature cannabis plants and seedlings and, cannabis flower, cannabis 
40.8 	products, lower-potency hemp edibles, and hemp-derived consumer products from another 
40.9 	cannabis microbusiness, a cannabis mezzobusiness, a cannabis cultivator, a cannabis 
40.10 	manufacturer, or a cannabis wholesaler, a medical cannabis combination business, a 
40.11 	lower-potency hemp edible manufacturer, or a lower-potency hemp edible wholesaler;
40.12 	(7) purchase hemp plant parts and propagules from an industrial hemp grower licensed 
40.13 	under chapter 18K;
40.14 	(8) purchase hemp concentrate from an industrial hemp processor licensed under chapter 
40.15 	18K;
40.16 	(9) purchase cannabis concentrate, hemp concentrate, and artificially derived cannabinoids 
40.17 	from another cannabis microbusiness, a cannabis mezzobusiness, a cannabis manufacturer, 
40.18 	or a cannabis wholesaler for use in manufacturing adult-use cannabis products, lower-potency 
40.19 	hemp edibles, or hemp-derived consumer products;
40.20 	(10) package and label adult-use cannabis flower, adult-use cannabis products, 
40.21 	lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;
40.22 	(11) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use 
40.23 	cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and 
40.24 	other products authorized by law to other cannabis businesses and to customers;
40.25 	(12) operate an establishment that permits on-site consumption of edible cannabis 
40.26 	products and lower-potency hemp edibles; and
40.27 	(13) perform other actions approved by the office.

40.28 	Sec. 10. Minnesota Statutes 2024, section 342.28, subdivision 8, is amended to read:
40.29 		Subd. 8.Production of customer consumer products endorsement. A cannabis 
40.30 	microbusiness that manufactures edible cannabis products, lower-potency hemp products, 
41.1 	or hemp-derived consumer products must comply with the requirements in section 342.26, 
41.2 	subdivisions 2 and 4.

41.3 	Sec. 11. Minnesota Statutes 2024, section 342.29, subdivision 1, is amended to read:
41.4 		Subdivision 1.Authorized actions. A cannabis mezzobusiness license, consistent with 
41.5 	the specific license endorsement or endorsements, entitles the license holder to perform any 
41.6 	or all of the following within the limits established by this section:
41.7 	(1) grow cannabis plants from seed or immature plant to mature plant and harvest 
41.8 	cannabis flower from a mature plant for use as adult-use cannabis flower or for use in 
41.9 	adult-use cannabis products;
41.10 	(2) grow cannabis plants from seed or immature plant to mature plant and harvest 
41.11 	cannabis flower from a mature plant for use as medical cannabis flower or for use in medical 
41.12 	cannabinoid products;
41.13 	(3) make cannabis concentrate;
41.14 	(4) make hemp concentrate, including hemp concentrate with a delta-9 
41.15 	tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;
41.16 	(5) manufacture artificially derived cannabinoids;
41.17 	(6) manufacture adult-use cannabis products, lower-potency hemp edibles, and 
41.18 	hemp-derived consumer products for public consumption;
41.19 	(7) process medical cannabinoid products;
41.20 	(8) purchase immature cannabis plants and seedlings and, cannabis flower, cannabis 
41.21 	products, lower-potency hemp edibles, and hemp-derived consumer products from a cannabis 
41.22 	microbusiness, another cannabis mezzobusiness, a cannabis cultivator, a cannabis 
41.23 	manufacturer, or a cannabis wholesaler, a medical cannabis combination business, a 
41.24 	lower-potency hemp edible manufacturer, or a lower-potency hemp edible wholesaler;
41.25 	(9) purchase cannabis concentrate, hemp concentrate, and synthetically artificially derived 
41.26 	cannabinoids from a cannabis microbusiness, another cannabis mezzobusiness, a cannabis 
41.27 	manufacturer, or a cannabis wholesaler for use in manufacturing adult-use cannabis products, 
41.28 	lower-potency hemp edibles, or hemp-derived consumer products;
41.29 	(10) purchase hemp plant parts and propagules from a licensed hemp grower licensed 
41.30 	under chapter 18K;
42.1 	(11) purchase hemp concentrate from an industrial hemp processor licensed under chapter 
42.2 	18K;
42.3 	(12) package and label adult-use cannabis flower, adult-use cannabis products, 
42.4 	lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;
42.5 	(13) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use 
42.6 	cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and 
42.7 	other products authorized by law to other cannabis businesses and to customers; and
42.8 	(14) perform other actions approved by the office.

42.9 	Sec. 12. Minnesota Statutes 2024, section 342.29, subdivision 7, is amended to read:
42.10 		Subd. 7.Production of customer consumer products endorsement. A cannabis 
42.11 	mezzobusiness that manufactures edible cannabis products, lower-potency hemp products, 
42.12 	or hemp-derived consumer products must comply with the requirements in section 342.26, 
42.13 	subdivisions 2 and 4.

42.14 	Sec. 13. Minnesota Statutes 2024, section 342.30, subdivision 1, is amended to read:
42.15 		Subdivision 1.Authorized actions. A cannabis cultivator license entitles the license 
42.16 	holder to:
42.17 	(1) grow cannabis plants within the approved amount of space from seed or immature 
42.18 	plant to mature plant,;
42.19 	(2) harvest cannabis flower from a mature plant,;
42.20 	(3) package and label immature cannabis plants and seedlings and cannabis flower for 
42.21 	sale to other cannabis businesses,;
42.22 	(4) sell immature cannabis plants and seedlings and cannabis flower to other cannabis 
42.23 	businesses;
42.24 	(5) transport cannabis flower to a cannabis manufacturer located on the same premises,;
42.25 	and
42.26 	(6) perform other actions approved by the office.

42.27 	Sec. 14. Minnesota Statutes 2024, section 342.32, subdivision 1, is amended to read:
42.28 		Subdivision 1.Authorized actions. A cannabis retailer license entitles the license holder 
42.29 	to:
43.1 	(1) purchase immature cannabis plants and seedlings, cannabis flower, cannabis products, 
43.2 	lower-potency hemp edibles, and hemp-derived consumer products from cannabis 
43.3 	microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers, 
43.4 	and cannabis wholesalers, and medical cannabis combination businesses;
43.5 	(2) purchase lower-potency hemp edibles from a licensed lower-potency hemp edible 
43.6 	manufacturer or lower-potency hemp edible wholesaler;
43.7 	(3) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use 
43.8 	cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and 
43.9 	other products authorized by law to customers; and
43.10 	(4) perform other actions approved by the office.

43.11 	Sec. 15. Minnesota Statutes 2024, section 342.32, subdivision 4, is amended to read:
43.12 		Subd. 4.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
43.13 	cannabis retailer license may also hold a cannabis delivery service license and a cannabis 
43.14 	event organizer license.
43.15 	(b) Except as provided in paragraph (a) and subdivision 5, no person, cooperative, or 
43.16 	business holding a cannabis retailer license may own or operate any other cannabis business 
43.17 	or hemp business.
43.18 	(c) No person, cooperative, or business may hold a license to own or operate more than 
43.19 	one cannabis retail business in one city and three retail businesses in one county.
43.20 	(d) The office by rule may limit the number of cannabis retailer licenses a person, 
43.21 	cooperative, or business may hold.
43.22 	(e) For purposes of this subdivision, a restriction on the number or type of license a 
43.23 	business may hold applies to every cooperative member or every director, manager, and 
43.24 	general partner of a cannabis business.

43.25 	Sec. 16. Minnesota Statutes 2024, section 342.32, subdivision 5, is amended to read:
43.26 		Subd. 5.Municipal or county cannabis store. A city or county may establish, own, 
43.27 	and operate a municipal cannabis store subject to the restrictions in this chapter.
43.28 	Notwithstanding any law to the contrary, a city or county that establishes, owns, or operates 
43.29 	a municipal cannabis store may also hold a lower-potency hemp edible retailer license.

44.1 	Sec. 17. Minnesota Statutes 2024, section 342.33, subdivision 1, is amended to read:
44.2 		Subdivision 1.Authorized actions. A cannabis wholesaler license entitles the license 
44.3 	holder to:
44.4 	(1) purchase immature cannabis plants and seedlings, cannabis flower, cannabis products, 
44.5 	lower-potency hemp edibles, and hemp-derived consumer products from cannabis 
44.6 	microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers, 
44.7 	medical cannabis combination businesses, and cannabis microbusinesses lower-potency 
44.8 	hemp edible manufacturers;
44.9 	(2) purchase hemp plant parts and propagules from industrial hemp growers licensed 
44.10 	under chapter 18K;
44.11 	(3) purchase hemp concentrate from an industrial hemp processor licensed under chapter 
44.12 	18K;
44.13 	(4) sell immature cannabis plants and seedlings, cannabis flower, cannabis products, 
44.14 	lower-potency hemp edibles, and hemp-derived consumer products to cannabis 
44.15 	microbusinesses, cannabis mezzobusinesses, cannabis manufacturers, and cannabis retailers;
44.16 	(5) sell lower-potency hemp edibles to lower-potency hemp edible retailers;
44.17 	(6) import hemp-derived consumer products and lower-potency hemp edibles that contain 
44.18 	hemp concentrate or artificially derived cannabinoids that are derived from hemp plants or 
44.19 	hemp plant parts; and
44.20 	(7) perform other actions approved by the office.

44.21 	Sec. 18. Minnesota Statutes 2024, section 342.36, subdivision 6, is amended to read:
44.22 		Subd. 6.Multiple employees; secured vehicles; delivery routes. All cannabis transporter 
44.23 	vehicles transporting immature cannabis plants and seedlings, cannabis flower, cannabis 
44.24 	products, artificially derived cannabinoids, hemp plant parts, hemp concentrate, 
44.25 	lower-potency hemp edibles, or hemp-derived consumer products must be staffed with a 
44.26 	minimum of two employees (1) secured by turning off the ignition, locking all doors and 
44.27 	storage compartments, and removing the operating keys or device, or (2) attended by a 
44.28 	cannabis transporter employee at all times. If there are multiple team members staffing an 
44.29 	unsecured transport vehicle, at least one delivery team member shall remain with the motor 
44.30 	vehicle at all times that the motor vehicle contains immature cannabis plants and seedlings, 
44.31 	cannabis flower, cannabis products, artificially derived cannabinoids, hemp plant parts, 
44.32 	hemp concentrate, lower-potency hemp edibles, or hemp-derived consumer products. A 
45.1 	cannabis transporter must not be required to randomize delivery times and routes or staff 
45.2 	cannabis transport vehicles with multiple employees.

45.3 	Sec. 19. Minnesota Statutes 2024, section 342.37, is amended by adding a subdivision to 
45.4 	read:
45.5 		Subd. 2a.Cannabis testing facility licenses. (a) Pending an applicant's accreditation 
45.6 	by a laboratory accrediting organization approved by the office, the office may issue or 
45.7 	renew a cannabis testing facility license for an applicant that is a person, cooperative, or 
45.8 	business if the applicant:
45.9 	(1) submits documentation to the office demonstrating that the applicant has a signed 
45.10 	contract with a laboratory accreditation organization approved by the office, has scheduled 
45.11 	an audit, and is making progress toward accreditation by a laboratory accrediting organization 
45.12 	approved by the office according to the standards of the most recent edition of ISO/IEC 
45.13 	17025: General Requirements for the Competence of Testing and Calibration Laboratories;
45.14 	(2) passes a final site inspection conducted by the office; and
45.15 	(3) meets all other licensing requirements according to chapter 342 and Minnesota Rules.
45.16 	(b) After receiving a license under this section, a license holder may operate a cannabis 
45.17 	testing facility up to one year with pending accreditation status.
45.18 	(c) If after one year a license holder continues to have pending accreditation status, the 
45.19 	license holder may apply for a onetime extension to continue operations for up to six months. 
45.20 	The office may grant an extension under this paragraph to a license holder if the license 
45.21 	holder:
45.22 	(1) passes a follow-up site inspection conducted by the office;
45.23 	(2) submits an initial audit report from a laboratory accrediting organization approved 
45.24 	by the office; and
45.25 	(3) submits any additional information requested by the office.
45.26 	(d) The office may revoke a cannabis testing facility license held by a license holder 
45.27 	with pending accreditation status if the office determines or has reason to believe that the 
45.28 	license holder:
45.29 	(1) is not making progress toward accreditation; or
45.30 	(2) has violated a cannabis testing requirement, an ownership requirement, or an 
45.31 	operational requirement in chapter 342 or Minnesota Rules.
46.1 	(e) The office must not issue or renew a cannabis testing facility license under this 
46.2 	subdivision for a license holder if the license holder's accreditation has been suspended or 
46.3 	revoked by a laboratory accrediting organization.

46.4 	Sec. 20. Minnesota Statutes 2024, section 342.37, is amended by adding a subdivision to 
46.5 	read:
46.6 		Subd. 2b.Loss of accreditation. (a) A license holder must report loss of accreditation 
46.7 	to the office within 24 hours of receiving notice of the loss of accreditation.
46.8 	(b) The office must immediately revoke a license holder's license upon receiving notice 
46.9 	that the license holder has lost accreditation.

46.10 	Sec. 21. Minnesota Statutes 2024, section 342.43, is amended by adding a subdivision to 
46.11 	read:
46.12 		Subd. 3.Exception; municipal or county licenses. Notwithstanding any law to the 
46.13 	contrary, a city or county that establishes, owns, or operates a municipal cannabis store may 
46.14 	also hold a lower-potency hemp edible retailer license.

46.15 	Sec. 22. Minnesota Statutes 2024, section 342.61, subdivision 4, is amended to read:
46.16 		Subd. 4.Testing of samples; disclosures. (a) On a schedule determined by the office, 
46.17 	every cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
46.18 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
46.19 	hemp edible manufacturer, or medical cannabis combination business shall make each batch 
46.20 	of cannabis flower, cannabis products, artificially derived cannabinoids, lower-potency 
46.21 	hemp edibles, or hemp-derived consumer products grown, manufactured, or imported by 
46.22 	the cannabis business or hemp business available to a cannabis testing facility.
46.23 	(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
46.24 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
46.25 	hemp edible manufacturer, or medical cannabis combination business must disclose all 
46.26 	known information regarding pesticides, fertilizers, solvents, or other foreign materials, 
46.27 	including but not limited to catalysts used in creating artificially derived cannabinoids, 
46.28 	applied or added to the batch of cannabis flower, cannabis products, artificially derived 
46.29 	cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products subject to 
46.30 	testing. Disclosure must be made to the cannabis testing facility and must include information 
46.31 	about all applications by any person, whether intentional or accidental.
47.1 	(c) The A cannabis testing facility business shall select one or more representative 
47.2 	samples from each batch, test the samples for the presence of contaminants, and test the 
47.3 	samples for potency and homogeneity and to allow the cannabis flower, cannabis product, 
47.4 	artificially derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer 
47.5 	product to be accurately labeled with its cannabinoid profile. Testing for contaminants must 
47.6 	include testing for residual solvents, foreign material, microbiological contaminants, heavy 
47.7 	metals, pesticide residue, mycotoxins, and any items identified pursuant to paragraph (b), 
47.8 	and may include testing for other contaminants. A cannabis testing facility must destroy or 
47.9 	return to the cannabis business or hemp business any part of the sample that remains after 
47.10 	testing.

47.11 	Sec. 23. Minnesota Statutes 2024, section 342.63, subdivision 2, is amended to read:
47.12 		Subd. 2.Content of label; cannabis. All cannabis flower and hemp-derived consumer 
47.13 	products that consist of hemp plant parts sold to customers or patients must have affixed 
47.14 	on the packaging or container of the cannabis flower or hemp-derived consumer product a 
47.15 	label that contains at least the following information:
47.16 	(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness, 
47.17 	cannabis cultivator, medical cannabis combination business, or industrial hemp grower 
47.18 	where the cannabis flower or hemp plant part was cultivated;
47.19 	(2) the net weight or volume of cannabis flower or hemp plant parts in the package or 
47.20 	container;
47.21 	(3) the batch number;
47.22 	(4) the cannabinoid profile;
47.23 	(5) a universal symbol established by the office indicating that the package or container 
47.24 	contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a 
47.25 	hemp-derived consumer product;
47.26 	(6) verification that the cannabis flower or hemp plant part was tested according to 
47.27 	section 342.61 and that the cannabis flower or hemp plant part complies with the applicable 
47.28 	standards;
47.29 	(7) information on the usage of the cannabis flower or hemp-derived consumer product;
47.30 	(8) the following statement: "Keep this product out of reach of children."; and
47.31 	(9) any other statements or information required by the office.

48.1 	Sec. 24. Minnesota Statutes 2024, section 342.63, subdivision 3, is amended to read:
48.2 		Subd. 3.Content of label; cannabinoid products. (a) All cannabis products, 
48.3 	lower-potency hemp edibles, hemp concentrate, hemp-derived consumer products other 
48.4 	than products subject to the requirements under subdivision 2, medical cannabinoid products, 
48.5 	and hemp-derived topical products sold to customers or patients must have affixed to the 
48.6 	packaging or container of the cannabis product a label that contains at least the following 
48.7 	information:
48.8 	(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness, 
48.9 	cannabis cultivator, medical cannabis combination business, or industrial hemp grower that 
48.10 	cultivated the cannabis flower or hemp plant parts used in the cannabis product, 
48.11 	lower-potency hemp edible, hemp-derived consumer product, or medical cannabinoid 
48.12 	product;
48.13 	(2) the name and license number of the cannabis microbusiness, cannabis mezzobusiness, 
48.14 	cannabis manufacturer, lower-potency hemp edible manufacturer, medical cannabis 
48.15 	combination business, or industrial hemp grower that manufactured the cannabis concentrate, 
48.16 	hemp concentrate, or artificially derived cannabinoid and, if different, the name and license 
48.17 	number of the cannabis microbusiness, cannabis mezzobusiness, cannabis manufacturer, 
48.18 	lower-potency hemp edible manufacturer, or medical cannabis combination business that 
48.19 	manufactured the product;
48.20 	(3) the net weight or volume of the cannabis product, lower-potency hemp edible, or 
48.21 	hemp-derived consumer product in the package or container;
48.22 	(4) the type of cannabis product, lower-potency hemp edible, or hemp-derived consumer 
48.23 	product;
48.24 	(5) the batch number;
48.25 	(6) the serving size;
48.26 	(7) the cannabinoid profile per serving and in total;
48.27 	(8) a list of ingredients;
48.28 	(9) a universal symbol established by the office indicating that the package or container 
48.29 	contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a 
48.30 	hemp-derived consumer product;
48.31 	(10) a warning symbol developed by the office in consultation with the commissioner 
48.32 	of health and the Minnesota Poison Control System that:
49.1 	(i) is at least three-quarters of an inch tall and six-tenths of an inch wide;
49.2 	(ii) is in a highly visible color;
49.3 	(iii) includes a visual element that is commonly understood to mean a person should 
49.4 	stop;
49.5 	(iv) indicates that the product is not for children; and
49.6 	(v) includes the phone number of the Minnesota Poison Control System;
49.7 	(11) verification that the cannabis product, lower-potency hemp edible, hemp-derived 
49.8 	consumer product, or medical cannabinoid product was tested according to section 342.61 
49.9 	and that the cannabis product, lower-potency hemp edible, hemp-derived consumer product, 
49.10 	or medical cannabinoid product complies with the applicable standards;
49.11 	(12) information on the usage of the product;
49.12 	(13) the following statement: "Keep this product out of reach of children."; and
49.13 	(14) any other statements or information required by the office.
49.14 	(b) The office may by rule establish alternative labeling requirements for lower-potency 
49.15 	hemp edibles that are imported into the state if those requirements provide consumers with 
49.16 	information that is substantially similar to the information described in paragraph (a).

49.17 	Sec. 25. Minnesota Statutes 2024, section 342.63, subdivision 6, is amended to read:
49.18 		Subd. 6.Additional information. (a) A cannabis microbusiness, cannabis mezzobusiness, 
49.19 	cannabis retailer, or medical cannabis combination business must provide customers and 
49.20 	patients with the following information:
49.21 	(1) factual information about impairment effects and the expected timing of impairment 
49.22 	effects, side effects, adverse effects, and health risks of cannabis flower, cannabis products, 
49.23 	lower-potency hemp edibles, and hemp-derived consumer products;
49.24 	(2) a statement that customers and patients must not operate a motor vehicle or heavy 
49.25 	machinery while under the influence of cannabis flower, cannabis products, lower-potency 
49.26 	hemp edibles, and hemp-derived consumer products;
49.27 	(3) resources customers and patients may consult to answer questions about cannabis 
49.28 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
49.29 	products, and any side effects and adverse effects;
49.30 	(4) contact information for the poison control center and a safety hotline or website for 
49.31 	customers to report and obtain advice about side effects and adverse effects of cannabis 
50.1 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
50.2 	products;
50.3 	(5) substance use disorder treatment options; and
50.4 	(6) any other information specified by the office.
50.5 	(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, or medical 
50.6 	cannabis combination business may include the information described in paragraph (a) by:
50.7 	(1) including the information on the label affixed to the packaging or container of cannabis 
50.8 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer products 
50.9 	by:;
50.10 	(1) (2) posting the information in the premises of the cannabis microbusiness, cannabis 
50.11 	mezzobusiness, cannabis retailer, or medical cannabis combination business; or
50.12 	(2) (3) providing the information on a separate document or pamphlet provided to 
50.13 	customers or patients when the customer purchases cannabis flower, a cannabis product, a 
50.14 	lower-potency hemp edible, or a hemp-derived consumer product.

50.15 	Sec. 26. Minnesota Statutes 2024, section 342.64, subdivision 1, is amended to read:
50.16 		Subdivision 1.Limitations applicable to all advertisements. Cannabis businesses, 
50.17 	hemp businesses, and other persons shall not publish or cause to be published an 
50.18 	advertisement for a cannabis business, a hemp business, cannabis flower, a cannabis product, 
50.19 	a lower-potency hemp edible, or a hemp-derived consumer product in a manner that:
50.20 	(1) contains false or misleading statements;
50.21 	(2) contains unverified claims about the health or therapeutic benefits or effects of 
50.22 	consuming cannabis flower, a cannabis product, a lower-potency hemp edible, or a 
50.23 	hemp-derived consumer product;
50.24 	(3) promotes the overconsumption of cannabis flower, a cannabis product, a 
50.25 	lower-potency hemp edible, or a hemp-derived consumer product;
50.26 	(4) promotes the consumption of alcohol while consuming cannabis flower, a cannabis 
50.27 	product, a lower-potency hemp edible, or a hemp-derived consumer product;
50.28 	(4) (5) depicts a person under 21 years of age consuming cannabis flower, a cannabis 
50.29 	product, a lower-potency hemp edible, or a hemp-derived consumer product; or
50.30 	(5) (6) includes an image designed or likely to appeal to individuals under 21 years of 
50.31 	age, including cartoons, toys, animals, or children, or any other likeness to images, characters, 
51.1 	or phrases that is designed to be appealing to individuals under 21 years of age or encourage 
51.2 	consumption by individuals under 21 years of age;
51.3 	(6) (7) contains an image of alcohol or a person or persons consuming alcohol; and
51.4 	(7) (8) does not contain a warning as specified by the office regarding impairment and 
51.5 	health risks.

51.6 	Sec. 27. REPEALER.
 51.7 	Minnesota Statutes 2024, section 342.36, subdivision 5, is repealed.

51.8 	ARTICLE 3
51.9 	HEMP BUSINESS REGULATIONS

51.10 	Section 1. Minnesota Statutes 2024, section 151.72, subdivision 3, is amended to read:
51.11 		Subd. 3.Sale of cannabinoids derived from hemp. (a) Notwithstanding any other 
51.12 	section of this chapter, a product containing nonintoxicating cannabinoids, including an 
51.13 	edible cannabinoid product, may be sold for human or animal consumption only if all of 
51.14 	the requirements of this section are met. A product sold for human or animal consumption 
51.15 	must not contain more than 0.3 percent of any tetrahydrocannabinol and an edible 
51.16 	cannabinoid product must not contain an amount of any tetrahydrocannabinol that exceeds 
51.17 	the limits established in subdivision 5a, paragraph (f).
51.18 	(b) A product containing nonintoxicating cannabinoids, other than an edible cannabinoid 
51.19 	product, may be sold for human or animal consumption only if it is intended for application 
51.20 	externally to a part of the body of a human or animal. Such a product must not be 
51.21 	manufactured, marketed, distributed, or intended to be consumed:
51.22 	(1) by combustion or vaporization of the product and inhalation of smoke, aerosol, or 
51.23 	vapor from the product;
51.24 	(2) through chewing, drinking, or swallowing; or
51.25 	(3) through injection or application to nonintact skin or a mucous membrane or nonintact 
51.26 	skin, except for products applied sublingually.
51.27 	(c) No other substance extracted or otherwise derived from hemp may be sold for human 
51.28 	consumption if the substance is intended:
51.29 	(1) for external or internal use in the diagnosis, cure, mitigation, treatment, or prevention 
51.30 	of disease in humans or other animals; or
52.1 	(2) to affect the structure or any function of the bodies of humans or other animals.
52.2 	(d) No product containing any cannabinoid or tetrahydrocannabinol extracted or otherwise 
52.3 	derived from hemp may be sold to any individual who is under the age of 21.
52.4 	(e) Products that meet the requirements of this section are not controlled substances 
52.5 	under section 152.02.
52.6 	(f) Products may be sold for on-site consumption if all of the following conditions are 
52.7 	met:
52.8 	(1) the retailer must also hold an on-sale license issued under chapter 340A;
52.9 	(2) products, other than products that are intended to be consumed as a beverage, must 
52.10 	be served in original packaging, but may be removed from the products' packaging by 
52.11 	customers and consumed on site;
52.12 	(3) products must not be sold to a customer who the retailer knows or reasonably should 
52.13 	know is intoxicated;
52.14 	(4) products must not be permitted to be mixed with an alcoholic beverage; and
52.15 	(5) products that have been removed from packaging must not be removed from the 
52.16 	premises.
52.17 	(g) Edible cannabinoid products that are intended to be consumed as a beverage may be 
52.18 	served outside of the products' packaging if the information that is required to be contained 
52.19 	on the label of an edible cannabinoid product is posted or otherwise displayed by the retailer.

52.20 	Sec. 2. Minnesota Statutes 2024, section 151.72, subdivision 5a, is amended to read:
52.21 		Subd. 5a.Additional requirements for edible cannabinoid products. (a) In addition 
52.22 	to the testing and labeling requirements under subdivisions 4 and 5, an edible cannabinoid 
52.23 	must meet the requirements of this subdivision.
52.24 	(b) An edible cannabinoid product must not:
52.25 	(1) bear the likeness or contain cartoon-like characteristics of a real or fictional person, 
52.26 	animal, or fruit that appeals to children;
52.27 	(2) be modeled after a brand of products primarily consumed by or marketed to children;
52.28 	(3) be made by applying an extracted or concentrated hemp-derived cannabinoid to a 
52.29 	commercially available candy or snack food item;
53.1 	(4) be substantively similar to a meat food product; poultry food product as defined in 
53.2 	section 31A.02, subdivision 10; or a dairy product as defined in section 32D.01, subdivision 
53.3 	7;
53.4 	(5) contain an ingredient, other than a hemp-derived cannabinoid, that is not approved 
53.5 	by the United States Food and Drug Administration for use in food;
53.6 	(6) be packaged in a way that resembles the trademarked, characteristic, or 
53.7 	product-specialized packaging of any commercially available food product; or
53.8 	(7) be packaged in a container that includes a statement, artwork, or design that could 
53.9 	reasonably mislead any person to believe that the package contains anything other than an 
53.10 	edible cannabinoid product.
53.11 	(c) An edible cannabinoid product must be prepackaged in packaging or a container that 
53.12 	is child-resistant, tamper-evident, and opaque or placed in packaging or a container that is 
53.13 	child-resistant, tamper-evident, and opaque at the final point of sale to a customer. The 
53.14 	requirement that packaging be child-resistant does not apply to an edible cannabinoid product 
53.15 	that is intended to be consumed as a beverage.
53.16 	(d) If an edible cannabinoid product, other than a product that is intended to be consumed 
53.17 	as a beverage, is intended for more than a single use or contains multiple servings, each 
53.18 	serving must be indicated by scoring, wrapping, or other indicators designating the individual 
53.19 	serving size that appear on the edible cannabinoid product. If it is not possible to indicate 
53.20 	a single serving by scoring or use of another indicator that appears on the product, the edible 
53.21 	cannabinoid product may not be packaged in a manner that includes more than a single 
53.22 	serving in each container, except that a calibrated dropper, measuring spoon, or similar 
53.23 	device for measuring a single serving, when sold with the product, may be used for any 
53.24 	edible cannabinoid products that are intended to be combined with food or beverage products 
53.25 	prior to consumption.
53.26 	(e) A label containing at least the following information must be affixed to the packaging 
53.27 	or container of all edible cannabinoid products sold to consumers:
53.28 	(1) the serving size;
53.29 	(2) the cannabinoid profile per serving and in total;
53.30 	(3) a list of ingredients, including identification of any major food allergens declared 
53.31 	by name; and
53.32 	(4) the following statement: "Keep this product out of reach of children."
54.1 	(f) An edible cannabinoid product that is not intended to be consumed as a beverage 
54.2 	must not contain more than five milligrams of any tetrahydrocannabinol in a single serving. 
54.3 	An edible cannabinoid product, other than a product that is intended to be consumed as a 
54.4 	beverage, may and must not contain more than a total of 50 milligrams of any 
54.5 	tetrahydrocannabinol per package. An edible cannabinoid product that is intended to be 
54.6 	consumed as a beverage may not contain more than two servings per container.
54.7 	(g) An edible cannabinoid product that is intended to be consumed as a beverage must 
54.8 	not contain more than ten milligrams of any tetrahydrocannabinol in a single container.
54.9 	(g)(h) An edible cannabinoid product may contain delta-8 tetrahydrocannabinol or 
54.10 	delta-9 tetrahydrocannabinol that is extracted from hemp plants or hemp plant parts or is 
54.11 	an artificially derived cannabinoid. Edible cannabinoid products are prohibited from 
54.12 	containing any other artificially derived cannabinoid, including but not limited to THC-P, 
54.13 	THC-O, and HHC, unless the office authorizes use of the artificially derived cannabinoid 
54.14 	in edible cannabinoid products. Edible cannabinoid products are prohibited from containing 
54.15 	synthetic cannabinoids.
54.16 	(h) (i) Every person selling edible cannabinoid products to consumers, other than products 
54.17 	that are intended to be consumed as a beverage, must ensure that all edible cannabinoid 
54.18 	products are displayed behind a checkout counter where the public is not permitted or in a 
54.19 	locked case.

54.20 	EFFECTIVE DATE. This section is effective the day following final enactment.

54.21 	Sec. 3. Minnesota Statutes 2024, section 342.01, subdivision 9, is amended to read:
54.22 		Subd. 9.Bona fide labor organization. "Bona fide labor organization" means a labor 
54.23 	union that represents or is actively seeking to represent cannabis workers. of:
54.24 	(1) a cannabis business; or
54.25 	(2) a lower-potency hemp edible manufacturer.

54.26 	Sec. 4. Minnesota Statutes 2024, section 342.01, subdivision 34, is amended to read:
54.27 		Subd. 34.Hemp business. (a) "Hemp business" means either any of the following 
54.28 	licensed under this chapter:
54.29 	(1) lower-potency hemp edible manufacturer; or
54.30 	(2) lower-potency hemp edible wholesaler; or
54.31 	(2) (3) lower-potency hemp edible retailer.
55.1 	(b) Hemp business does not include a person or entity licensed under chapter 18K to 
55.2 	grow industrial hemp for commercial or research purposes or to process industrial hemp 
55.3 	for commercial purposes.

55.4 	EFFECTIVE DATE. This section is effective the day following final enactment.

55.5 	Sec. 5. Minnesota Statutes 2024, section 342.01, subdivision 47, is amended to read:
55.6 		Subd. 47.Labor peace agreement. "Labor peace agreement" means an agreement 
55.7 	between a cannabis business and a bona fide labor organization or an agreement between 
55.8 	a lower-potency hemp edible manufacturer and a bona fide labor organization that protects 
55.9 	the state's interests by, at minimum, prohibiting the labor organization from engaging in 
55.10 	picketing, work stoppages, or boycotts against the cannabis business or lower-potency hemp 
55.11 	edible manufacturer.

55.12 	Sec. 6. Minnesota Statutes 2024, section 342.01, subdivision 48, is amended to read:
55.13 		Subd. 48.License holder. "License holder" means a person, cooperative, or business 
55.14 	that holds any of the following licenses:
55.15 	(1) cannabis microbusiness;
55.16 	(2) cannabis mezzobusiness;
55.17 	(3) cannabis cultivator;
55.18 	(4) cannabis manufacturer;
55.19 	(5) cannabis retailer;
55.20 	(6) cannabis wholesaler;
55.21 	(7) cannabis transporter;
55.22 	(8) cannabis testing facility;
55.23 	(9) cannabis event organizer;
55.24 	(10) cannabis delivery service;
55.25 	(11) lower-potency hemp edible manufacturer;
55.26 	(12) lower-potency hemp edible wholesaler;
55.27 	(12) (13) lower-potency hemp edible retailer; or
55.28 	(13) (14) medical cannabis combination business.

56.1 	EFFECTIVE DATE. This section is effective the day following final enactment.

56.2 	Sec. 7. Minnesota Statutes 2024, section 342.01, subdivision 50, is amended to read:
56.3 		Subd. 50.Lower-potency hemp edible. (a) "Lower-potency hemp edible" means any 
56.4 	product that:
56.5 	(1) is intended to be eaten or consumed as a beverage by humans;
56.6 	(2) contains hemp concentrate or an artificially derived cannabinoid, in combination 
56.7 	with food ingredients;
56.8 	(3) is not a drug;
56.9 	(4) does not contain a cannabinoid derived from cannabis plants or cannabis flower;
56.10 	(5) is a type of product approved for sale by the office or is substantially similar to a 
56.11 	product approved by the office, including but not limited to products that resemble 
56.12 	nonalcoholic beverages, candy, and baked goods; and
56.13 	(6) meets either of the requirements in paragraph (b).
56.14 	(b) A lower-potency hemp edible includes:
56.15 	(1) a product that:
56.16 	(i) is not intended to be consumed as a beverage and consists of servings that contain 
56.17 	no more than five milligrams of delta-9 tetrahydrocannabinol; is intended to be consumed 
56.18 	as a beverage and contains no more than ten milligrams of delta-9 tetrahydrocannabinol in 
56.19 	a single container; is intended to be consumed in any approved manner and consists of 
56.20 	servings or a container that contain no more than 25 100 milligrams of cannabidiol, 
56.21 	cannabigerol, cannabinol, or cannabichromene; is intended to be consumed in any approved 
56.22 	manner and contains no more than the established limit of any other cannabinoid authorized 
56.23 	by the office; or is intended to be consumed in any approved manner and contains any 
56.24 	combination of those cannabinoids that does not exceed the identified amounts for the 
56.25 	applicable product category;
56.26 	(ii) does not contain more than a combined total of 0.5 milligrams of all other 
56.27 	cannabinoids per serving; and
56.28 	(iii) does not contain an artificially derived cannabinoid other than delta-9 
56.29 	tetrahydrocannabinol, except that a product may include artificially derived cannabinoids 
56.30 	created during the process of creating the delta-9 tetrahydrocannabinol that is added to the 
56.31 	product, if no artificially derived cannabinoid is added to the ingredient containing delta-9 
57.1 	tetrahydrocannabinol and the ratio of delta-9 tetrahydrocannabinol to all other artificially 
57.2 	derived cannabinoids is no less than 20 to one; or
57.3 	(2) a product that:
57.4 	(i) contains hemp concentrate processed or refined without increasing the percentage of 
57.5 	targeted cannabinoids or altering the ratio of cannabinoids in the extracts or resins of a hemp 
57.6 	plant or hemp plant parts beyond the variability generally recognized for the method used 
57.7 	for processing or refining or by an amount needed to reduce the total THC in the hemp 
57.8 	concentrate; and
57.9 	(ii) consists of servings that contain no more than five milligrams of total THC.

57.10 	EFFECTIVE DATE. This section is effective the day following final enactment.

57.11 	Sec. 8. Minnesota Statutes 2024, section 342.10, is amended to read:
57.12 	342.10 LICENSES; TYPES.
57.13 	The office shall issue the following types of license:
57.14 	(1) cannabis microbusiness;
57.15 	(2) cannabis mezzobusiness;
57.16 	(3) cannabis cultivator;
57.17 	(4) cannabis manufacturer;
57.18 	(5) cannabis retailer;
57.19 	(6) cannabis wholesaler;
57.20 	(7) cannabis transporter;
57.21 	(8) cannabis testing facility;
57.22 	(9) cannabis event organizer;
57.23 	(10) cannabis delivery service;
57.24 	(11) lower-potency hemp edible manufacturer;
57.25 	(12) lower-potency hemp edible wholesaler;
57.26 	(12) (13) lower-potency hemp edible retailer; and
57.27 	(13) (14) medical cannabis combination business.

57.28 	EFFECTIVE DATE. This section is effective the day following final enactment.

58.1 	Sec. 9. Minnesota Statutes 2024, section 342.11, is amended to read:
58.2 	342.11 LICENSES; FEES.
58.3 	(a) The office shall require the payment of application fees, initial licensing fees, and 
58.4 	renewal licensing fees as provided in this section. The initial license fee shall include the 
58.5 	fee for initial issuance of the license and the first annual renewal. The renewal fee shall be 
58.6 	charged at the time of the second renewal and each subsequent annual renewal thereafter. 
58.7 	Nothing in this section prohibits a local unit of government from charging the retailer 
58.8 	registration fee established in section 342.22. Application fees, initial licensing fees, and 
58.9 	renewal licensing fees are nonrefundable.
58.10 	(b) Application and licensing fees shall be as follows:
58.11 	(1) for a cannabis microbusiness:
58.12 	(i) an application fee of $500;
58.13 	(ii) an initial license fee of $0; and
58.14 	(iii) a renewal license fee of $2,000;
58.15 	(2) for a cannabis mezzobusiness:
58.16 	(i) an application fee of $5,000;
58.17 	(ii) an initial license fee of $5,000; and
58.18 	(iii) a renewal license fee of $10,000;
58.19 	(3) for a cannabis cultivator:
58.20 	(i) an application fee of $10,000;
58.21 	(ii) an initial license fee of $20,000; and
58.22 	(iii) a renewal license fee of $30,000;
58.23 	(4) for a cannabis manufacturer:
58.24 	(i) an application fee of $10,000;
58.25 	(ii) an initial license fee of $10,000; and
58.26 	(iii) a renewal license fee of $20,000;
58.27 	(5) for a cannabis retailer:
58.28 	(i) an application fee of $2,500;
58.29 	(ii) an initial license fee of $2,500; and
59.1 	(iii) a renewal license fee of $5,000;
59.2 	(6) for a cannabis wholesaler:
59.3 	(i) an application fee of $5,000;
59.4 	(ii) an initial license fee of $5,000; and
59.5 	(iii) a renewal license fee of $10,000;
59.6 	(7) for a cannabis transporter:
59.7 	(i) an application fee of $250;
59.8 	(ii) an initial license fee of $500; and
59.9 	(iii) a renewal license fee of $1,000;
59.10 	(8) for a cannabis testing facility:
59.11 	(i) an application fee of $5,000;
59.12 	(ii) an initial license fee of $5,000; and
59.13 	(iii) a renewal license fee of $10,000;
59.14 	(9) for a cannabis delivery service:
59.15 	(i) an application fee of $250;
59.16 	(ii) an initial license fee of $500; and
59.17 	(iii) a renewal license fee of $1,000;
59.18 	(10) for a cannabis event organizer:
59.19 	(i) an application fee of $750; and
59.20 	(ii) an initial license fee of $750;
59.21 	(11) for a lower-potency hemp edible manufacturer:
59.22 	(i) an application fee of $250;
59.23 	(ii) an initial license fee of $1,000; and
59.24 	(iii) a renewal license fee of $1,000;
59.25 	(12) for a lower-potency hemp edible wholesaler:
59.26 	(i) an application fee of $250;
59.27 	(ii) an initial license fee of $10,000; and
60.1 	(iii) a renewal license fee of $10,000;
60.2 	(12) (13) for a lower-potency hemp edible retailer:
60.3 	(i) an application fee of $250 or, if the lower-potency hemp retailer operates more than 
60.4 	one retail location, $250 per retail location;
60.5 	(ii) an initial license fee of $250 or, if the lower-potency hemp retailer operates more 
60.6 	than one retail location, $250 per retail location; and
60.7 	(iii) a renewal license fee of $250 or, if the lower-potency hemp retailer operates more 
60.8 	than one retail location, $250 per retail location; and
60.9 	(13) (14) for a medical cannabis combination business:
60.10 	(i) an application fee of $10,000;
60.11 	(ii) an initial license fee of $20,000; and
60.12 	(iii) a renewal license fee of $70,000.

60.13 	EFFECTIVE DATE. This section is effective the day following final enactment.

60.14 	Sec. 10. Minnesota Statutes 2024, section 342.13, is amended to read:
60.15 	342.13 LOCAL CONTROL.
60.16 	(a) A local unit of government may not prohibit the possession, transportation, or use 
60.17 	of cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived 
60.18 	consumer products authorized under this chapter.
60.19 	(b) Except as provided in section 342.22, a local unit of government may not prohibit 
60.20 	the establishment or operation of a cannabis business or hemp business licensed under this 
60.21 	chapter.
60.22 	(c) A local unit of government may adopt reasonable restrictions on the time, place, and 
60.23 	manner of the operation of a cannabis business provided that such restrictions do not prohibit 
60.24 	the establishment or operation of cannabis businesses. A local unit of government may 
60.25 	prohibit the operation of a cannabis business within 1,000 feet of a school, or 500 feet of a 
60.26 	day care, residential treatment facility, or an attraction within a public park that is regularly 
60.27 	used by minors, including a playground or athletic field.
60.28 	(d) The office shall work with local units of government to:
60.29 	(1) develop model ordinances for reasonable restrictions on the time, place, and manner 
60.30 	of the operation of a cannabis business;
61.1 	(2) develop standardized forms and procedures for the issuance of a retail registration 
61.2 	pursuant to section 342.22; and
61.3 	(3) develop model policies and procedures for the performance of compliance checks 
61.4 	required under section 342.22.
61.5 	(e) If a local unit of government is conducting studies or has authorized a study to be 
61.6 	conducted or has held or has scheduled a hearing for the purpose of considering adoption 
61.7 	or amendment of reasonable restrictions on the time, place, and manner of the operation of 
61.8 	a cannabis business, the governing body of the local unit of government may adopt an 
61.9 	interim ordinance applicable to all or part of its jurisdiction for the purpose of protecting 
61.10 	the planning process and the health, safety, and welfare of its citizens. Before adopting the 
61.11 	interim ordinance, the governing body must hold a public hearing. The interim ordinance 
61.12 	may regulate, restrict, or prohibit the operation of a cannabis business within the jurisdiction 
61.13 	or a portion thereof until January 1, 2025.
61.14 	(f) Within 30 days of receiving a copy of an application from the office, a local unit of 
61.15 	government shall certify on a form provided by the office whether a proposed cannabis 
61.16 	business complies with local zoning ordinances and, if applicable, whether the proposed 
61.17 	business complies with the state fire code and building code. The office may not issue a 
61.18 	license if the local unit of government informs the office that the cannabis business does 
61.19 	not meet local zoning and land use laws. If the local unit of government does not provide 
61.20 	the certification to the office within 30 days of receiving a copy of an application from the 
61.21 	office, the office may issue a license.
61.22 	(g) The office by rule shall establish an expedited complaint process to receive, review, 
61.23 	and respond to complaints made by a local unit of government about a cannabis business. 
61.24 	At a minimum, the expedited complaint process shall require the office to provide an initial 
61.25 	response to the complaint within seven days and perform any necessary inspections within 
61.26 	30 days. Nothing in this paragraph prohibits a local unit of government from enforcing a 
61.27 	local ordinance. If a local unit of government notifies the office that a cannabis business 
61.28 	other than a cannabis retailer, cannabis microbusiness or, cannabis mezzobusiness or 
61.29 	lower-potency hemp edible retailer with a retail operations endorsement, lower-potency 
61.30 	hemp edible retailer, or medical cannabis combination business operating a retail location 
61.31 	poses an immediate threat to the health or safety of the public, the office must respond 
61.32 	within one business day and may take any action described in section 342.19 or 342.21.
61.33 	(h) A local government unit that issues a cannabis retailer registration under section 
61.34 	342.22 may, by ordinance, limit the number of licensed cannabis retailers, cannabis 
62.1 	mezzobusinesses with a retail operations endorsement, and cannabis microbusinesses with 
62.2 	a retail operations endorsement to no fewer than one registration for every 12,500 residents.
62.3 	(i) If a county has one active registration for every 12,500 residents, a city or town within 
62.4 	the county is not obligated to register a cannabis business.
62.5 	(j) Nothing in this section shall prohibit a local government unit from allowing licensed 
62.6 	cannabis retailers in excess of the minimums set in paragraph (h).
62.7 	(k) Notwithstanding the foregoing provisions, the state shall not issue a license to any 
62.8 	cannabis business to operate in Indian country, as defined in United States Code, title 18, 
62.9 	section 1151, of a Minnesota Tribal government without the consent of the Tribal 
62.10 	government.

62.11 	EFFECTIVE DATE. This section is effective the day following final enactment.

62.12 	Sec. 11. Minnesota Statutes 2024, section 342.18, subdivision 2, is amended to read:
62.13 		Subd. 2.Vertical integration prohibited; exceptions. (a) Except as otherwise provided 
62.14 	in this subdivision, the office shall not issue licenses to a single applicant that would result 
62.15 	in the applicant being vertically integrated in violation of the provisions of this chapter.
62.16 	(b) Nothing in this section prohibits or limits the issuance of microbusiness licenses, 
62.17 	mezzobusiness licenses, or medical cannabis combination business licenses, or the issuance 
62.18 	of both lower-potency hemp edible manufacturer, lower-potency hemp edible wholesaler,
62.19 	and lower-potency hemp edible retailer licenses to the same person or entity.

62.20 	EFFECTIVE DATE. This section is effective the day following final enactment.

62.21 	Sec. 12. Minnesota Statutes 2024, section 342.22, is amended by adding a subdivision to 
62.22 	read:
62.23 		Subd. 6.Exception; exclusive delivery services. The requirements of this section do 
62.24 	not apply to a lower-potency hemp edible retailer with a delivery endorsement if the 
62.25 	lower-potency hemp edible retailer does not operate a retail location.

62.26 	EFFECTIVE DATE. This section is effective the day following final enactment.

62.27 	Sec. 13. Minnesota Statutes 2024, section 342.34, subdivision 5, is amended to read:
62.28 		Subd. 5.Importation of hemp-derived products. (a) A cannabis wholesaler that imports 
62.29 	lower-potency hemp edibles or hemp-derived consumer products, other than hemp-derived 
62.30 	topical products, that are manufactured outside the boundaries of the state of Minnesota 
63.1 	with the intent to sell the products to a cannabis microbusiness, cannabis mezzobusiness, 
63.2 	cannabis retailer, lower-potency hemp edible wholesaler, or lower-potency hemp edible 
63.3 	retailer must obtain a hemp-derived product importer endorsement from the office.
63.4 	(b) A cannabis wholesaler with a hemp-derived product importer endorsement may sell 
63.5 	products manufactured outside the boundaries of the state of Minnesota if:
63.6 	(1) the manufacturer is licensed in another jurisdiction and subject to regulations designed 
63.7 	to protect the health and safety of consumers that the office determines are substantially 
63.8 	similar to the regulations in this state; or
63.9 	(2) the cannabis wholesaler establishes, to the satisfaction of the office, that the 
63.10 	manufacturer engages in practices that are substantially similar to the practices required for 
63.11 	licensure of manufacturers in this state.
63.12 	(c) The cannabis wholesaler must enter all relevant information regarding an imported 
63.13 	hemp-derived consumer product into the statewide monitoring system before the product 
63.14 	may be distributed. Relevant information includes information regarding the cultivation, 
63.15 	processing, and testing of the industrial hemp used in the manufacture of the product and 
63.16 	information regarding the testing of the hemp-derived consumer product. If information 
63.17 	regarding the industrial hemp or hemp-derived consumer product was submitted to a 
63.18 	statewide monitoring system used in another state, the office may require submission of 
63.19 	any information provided to that statewide monitoring system and shall assist in the transfer 
63.20 	of data from another state as needed and in compliance with any data classification 
63.21 	established by either state.
63.22 	(d) The office may suspend, revoke, or cancel the endorsement of a distributor who is 
63.23 	prohibited from distributing products containing cannabinoids in any other jurisdiction, 
63.24 	convicted of an offense involving the distribution of products containing cannabinoids in 
63.25 	any other jurisdiction, or found liable for distributing any product that injured customers in 
63.26 	any other jurisdiction. A cannabis wholesaler shall disclose all relevant information related 
63.27 	to actions in another jurisdiction. Failure to disclose relevant information may result in 
63.28 	disciplinary action by the office, including the suspension, revocation, or cancellation of 
63.29 	an endorsement or license.
63.30 	(e) Notwithstanding any law to the contrary, it shall not be a defense in any civil or 
63.31 	criminal action that a licensed wholesaler relied on information on a product label or 
63.32 	otherwise provided by a manufacturer who is not licensed in this state.

63.33 	EFFECTIVE DATE. This section is effective the day following final enactment.

64.1 	Sec. 14. Minnesota Statutes 2024, section 342.39, subdivision 3, is amended to read:
64.2 		Subd. 3.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
64.3 	cannabis event organizer license may not hold a cannabis testing facility license, a 
64.4 	lower-potency hemp edible manufacturer license, a lower-potency hemp edible wholesaler 
64.5 	license, or a lower-potency hemp edible retailer license.
64.6 	(b) The office by rule may limit the number of cannabis event licenses that a person or 
64.7 	business may hold.
64.8 	(c) For purposes of this subdivision, restrictions on the number or type of license that a 
64.9 	business may hold apply to every cooperative member or every director, manager, and 
64.10 	general partner of a cannabis business.

64.11 	EFFECTIVE DATE. This section is effective the day following final enactment.

64.12 	Sec. 15. Minnesota Statutes 2024, section 342.43, subdivision 1, is amended to read:
64.13 		Subdivision 1.License types. The office shall issue the following types of hemp business 
64.14 	licenses:
64.15 	(1) lower-potency hemp edible manufacturer; and
64.16 	(2) lower-potency hemp edible wholesaler; and
64.17 	(2) (3) lower-potency hemp edible retailer.

64.18 	EFFECTIVE DATE. This section is effective the day following final enactment.

64.19 	Sec. 16. Minnesota Statutes 2024, section 342.43, subdivision 2, is amended to read:
64.20 		Subd. 2.Multiple licenses; limits. (a) A person, cooperative, or business may hold both
64.21 	any combination of a lower-potency hemp edible manufacturer, a lower-potency hemp 
64.22 	edible wholesaler, and a lower-potency hemp edible retailer license.
64.23 	(b) Nothing in this section prohibits a person, cooperative, or business from holding a 
64.24 	lower-potency hemp edible manufacturer license, a lower-potency hemp edible wholesaler 
64.25 	license, a lower-potency hemp edible retailer license, or both any combination of those 
64.26 	licenses, and also holding a license to cultivate industrial hemp issued pursuant to chapter 
64.27 	18K.
64.28 	(c) Nothing in this section prohibits a person, cooperative, or business from holding a 
64.29 	lower-potency hemp edible manufacturer license, a lower-potency hemp edible wholesaler 
64.30 	license, a lower-potency hemp edible retailer license, or both any combination of those 
65.1 	licenses, and also holding any other license, including but not limited to a license to prepare 
65.2 	or sell food; sell tobacco, tobacco-related devices, electronic delivery devices as defined in 
65.3 	section 609.685, subdivision 1, and nicotine and lobelia delivery products as described in 
65.4 	section 609.6855; or manufacture or sell alcoholic beverages as defined in section 340A.101, 
65.5 	subdivision 2.
65.6 	(d) A person, cooperative, or business holding a lower-potency hemp edible manufacturer 
65.7 	license, a lower-potency hemp edible wholesaler license, a lower-potency hemp edible 
65.8 	retailer license, or both any combination of those licenses, may not hold a cannabis business 
65.9 	license.

65.10 	EFFECTIVE DATE. This section is effective the day following final enactment.

65.11 	Sec. 17. Minnesota Statutes 2024, section 342.44, subdivision 1, is amended to read:
65.12 		Subdivision 1.Application; contents. (a) Except as otherwise provided in this 
65.13 	subdivision, the provisions of this chapter relating to license applications, license selection 
65.14 	criteria, general ownership disqualifications and requirements, and general operational 
65.15 	requirements do not apply to hemp businesses.
65.16 	(b) The office, by rule, shall establish forms and procedures for the processing of hemp 
65.17 	licenses issued under this chapter. At a minimum, any application to obtain or renew a hemp 
65.18 	license shall include the following information, if applicable:
65.19 	(1) the name, address, and date of birth of the applicant;
65.20 	(2) the address and legal property description of the business;
65.21 	(3) proof of trade name registration;
65.22 	(4) certification that the applicant will comply with the requirements of this chapter 
65.23 	relating to the ownership and operation of a hemp business;
65.24 	(5) identification of one or more controlling persons or managerial employees as agents 
65.25 	who shall be responsible for dealing with the office on all matters; and
65.26 	(6) a statement that the applicant agrees to respond to the office's supplemental requests 
65.27 	for information.
65.28 	(c) An applicant for a lower-potency hemp edible manufacturer license must submit an 
65.29 	attestation signed by a bona fide labor organization stating that the applicant has entered 
65.30 	into a labor peace agreement.
66.1 	(d) An application on behalf of a corporation or association shall be signed by at least 
66.2 	two officers or managing agents of that entity.

66.3 	EFFECTIVE DATE. This section is effective the day following final enactment.

66.4 	Sec. 18. Minnesota Statutes 2024, section 342.45, subdivision 1, is amended to read:
66.5 		Subdivision 1.Authorized actions. A lower-potency hemp edible manufacturer license, 
66.6 	consistent with the specific license endorsement or endorsements, entitles the license holder 
66.7 	to:
66.8 	(1) purchase hemp plant parts, hemp concentrate, and artificially derived cannabinoids 
66.9 	from cannabis microbusinesses, cannabis mezzobusinesses, cannabis manufacturers, cannabis 
66.10 	wholesalers, and lower-potency hemp edible manufacturers;
66.11 	(2) purchase hemp plant parts and propagules from industrial hemp growers licensed 
66.12 	under chapter 18K;
66.13 	(3) purchase hemp concentrate from an industrial hemp processor licensed under chapter 
66.14 	18K;
66.15 	(4) make hemp concentrate;
66.16 	(5) manufacture artificially derived cannabinoids;
66.17 	(6) manufacture lower-potency hemp edibles for public consumption;
66.18 	(7) package and label lower-potency hemp edibles for sale to customers;
66.19 	(8) sell hemp concentrate, artificially derived cannabinoids, and lower-potency hemp 
66.20 	edibles to other cannabis businesses and hemp businesses; and
66.21 	(9) manufacture, package, and label products containing cannabinoids that are intended 
66.22 	for sale outside of the state;
66.23 	(10) store products containing cannabinoids that are intended for sale outside of the 
66.24 	state;
66.25 	(11) sell products containing cannabinoids that do not qualify as lower-potency hemp 
66.26 	edibles to customers outside of the state; and
66.27 	(9) (12) perform other actions approved by the office.

67.1 	Sec. 19. Minnesota Statutes 2024, section 342.45, is amended by adding a subdivision to 
67.2 	read:
67.3 		Subd. 4a.Products intended for sale in other jurisdictions. (a) A lower-potency hemp 
67.4 	edible manufacturer that produces products containing cannabinoids that do not qualify as 
67.5 	lower-potency hemp edibles and are intended for sale only in jurisdictions other than 
67.6 	Minnesota must obtain a hemp product exporter endorsement from the office.
67.7 	(b) All areas within the premises of a lower-potency hemp edible manufacturer used for 
67.8 	producing products containing cannabinoids that do not qualify as lower-potency hemp 
67.9 	edibles must meet the sanitary standards specified in rules adopted by the office.
67.10 	(c) A lower-potency hemp edible manufacturer must not add any cannabis flower, 
67.11 	cannabis concentrate, or cannabinoid derived from cannabis flower or cannabis concentrate 
67.12 	to products containing cannabinoids that do not qualify as lower-potency hemp edibles.
67.13 	(d) All products containing cannabinoids that do not qualify as lower-potency hemp 
67.14 	edibles and are intended, distributed, and offered for sale only in jurisdictions other than 
67.15 	Minnesota must be physically separated from all lower-potency hemp edibles during the 
67.16 	manufacturing, packaging, and labeling process.
67.17 	(e) All products containing cannabinoids that do not qualify as lower-potency hemp 
67.18 	edibles and are intended, distributed, and offered for sale only in jurisdictions other than 
67.19 	Minnesota must be tested as provided in section 342.61 and must meet all standards 
67.20 	established by the office except for any limits on the amount of any cannabinoid a product 
67.21 	may contain. The packaging of such products must contain verification that the product was 
67.22 	tested according to section 342.61 and that the product complies with applicable standards 
67.23 	except for any limits on the amount of any cannabinoid a product may contain. The packaging 
67.24 	must also include the product's batch number and the cannabinoid profile per serving and 
67.25 	in total.
67.26 	(f) The packaging of all products containing cannabinoids that do not qualify as 
67.27 	lower-potency hemp edibles and are intended, distributed, and offered for sale only in 
67.28 	jurisdictions other than Minnesota must clearly state that the products are not for sale in 
67.29 	Minnesota.
67.30 	(g) A lower-potency hemp edible manufacturer must not sell or offer for sale products 
67.31 	containing cannabinoids that do not qualify as lower-potency hemp edibles in Minnesota 
67.32 	and must not manufacture, distribute, or store such products knowing or having reason to 
67.33 	know that the products will be sold in Minnesota.
68.1 	(h) The office may suspend, revoke, or cancel the license or endorsement of a 
68.2 	lower-potency hemp edible manufacturer who is prohibited from distributing products 
68.3 	containing cannabinoids in any other jurisdiction, convicted of an offense involving the 
68.4 	distribution of products containing cannabinoids in any other jurisdiction, or found liable 
68.5 	for distributing any product that injured customers in any other jurisdiction. A lower-potency 
68.6 	hemp edible manufacturer shall disclose all relevant information related to actions in another 
68.7 	jurisdiction. Failure to disclose relevant information may result in disciplinary action by 
68.8 	the office, including the suspension, revocation, or cancellation of an endorsement or license.

68.9 	Sec. 20. Minnesota Statutes 2024, section 342.45, is amended by adding a subdivision to 
68.10 	read:
68.11 		Subd. 6.Building conditions. (a) A lower-potency hemp edible manufacturer must 
68.12 	comply with state and local building, fire, and zoning codes, requirements, and regulations.
68.13 	(b) A lower-potency hemp edible manufacturer must ensure that licensed premises are 
68.14 	maintained in a clean and sanitary condition and are free from infestation by insects, rodents, 
68.15 	or other pests.

68.16 	Sec. 21. [342.455] LOWER-POTENCY HEMP EDIBLE WHOLESALER.
68.17 		Subdivision 1.Authorized actions. A lower-potency hemp edible wholesaler license, 
68.18 	consistent with the specific license endorsement or endorsements, entitles the license holder 
68.19 	to perform any or all of the following within the limits established by this section:
68.20 	(1) purchase lower-potency hemp edibles from cannabis microbusinesses, cannabis 
68.21 	mezzobusinesses, cannabis cultivators, cannabis manufacturers, cannabis wholesalers, other 
68.22 	lower-potency hemp edible wholesalers, and lower-potency hemp edible manufacturers;
68.23 	(2) sell lower-potency hemp edibles to lower-potency hemp edible retailers with a retail 
68.24 	endorsement, cannabis microbusinesses with a retail endorsement, cannabis mezzobusinesses 
68.25 	with a retail endorsement, cannabis retailers, cannabis wholesalers, medical cannabis 
68.26 	combination businesses, and other lower-potency hemp edible wholesalers;
68.27 	(3) import lower-potency hemp edibles that contain hemp concentrate or artificially 
68.28 	derived cannabinoids that are derived from hemp plants or hemp plant parts;
68.29 	(4) purchase and store products containing cannabinoids that are intended for sale outside 
68.30 	of the state;
68.31 	(5) sell products containing cannabinoids that do not qualify as lower-potency hemp 
68.32 	edibles to customers outside of the state; and
69.1 	(6) perform other actions approved by the office.
69.2 		Subd. 2.Operations. (a) A lower-potency hemp edible wholesaler must maintain accurate 
69.3 	records and ensure that appropriate labels remain affixed to lower-potency hemp edibles.
69.4 	(b) A lower-potency hemp edible wholesaler must maintain compliance with state and 
69.5 	local building, fire, and zoning requirements or regulations and must ensure that the 
69.6 	wholesaler's premises are maintained in a clean and sanitary condition, free from infestation 
69.7 	by insects, rodents, or other pests.
69.8 	(c) A lower-potency hemp edible wholesaler may purchase and sell other products or 
69.9 	items for which the wholesaler has a license or an authorization or that do not require a 
69.10 	license or an authorization. Products for which no license or authorization is required include 
69.11 	but are not limited to industrial hemp products, products that contain hemp grain, 
69.12 	hemp-derived topical products, and cannabis paraphernalia. Cannabis paraphernalia includes 
69.13 	but is not limited to childproof packaging containers and other devices designed to ensure 
69.14 	the safe storage and monitoring of cannabis flower and cannabis products in the home to 
69.15 	prevent access by individuals under 21 years of age.
69.16 		Subd. 3.Importation of lower-potency hemp edibles; endorsement. (a) A 
69.17 	lower-potency hemp edible wholesaler that imports lower-potency hemp edibles that are 
69.18 	manufactured outside the boundaries of the state of Minnesota with the intent to sell the 
69.19 	products to a cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, cannabis 
69.20 	wholesaler, medical cannabis combination business, other lower-potency hemp edible 
69.21 	wholesaler, or lower-potency hemp edible retailer must obtain a lower-potency hemp edible 
69.22 	importer endorsement from the office.
69.23 	(b) A lower-potency hemp edible wholesaler with an endorsement issued under this 
69.24 	subdivision may sell products manufactured outside the boundaries of the state of Minnesota 
69.25 	if:
69.26 	(1) the manufacturer is licensed in another jurisdiction and subject to regulations designed 
69.27 	to protect the health and safety of consumers that the office determines are substantially 
69.28 	similar to the regulations in this state; or
69.29 	(2) the lower-potency hemp edible wholesaler establishes, to the satisfaction of the office, 
69.30 	that the manufacturer engages in practices that are substantially similar to the practices 
69.31 	required for licensure of manufacturers in this state.
69.32 	(c) The office may suspend, revoke, or cancel the license or endorsement of a wholesaler 
69.33 	who is prohibited from distributing products containing cannabinoids in any other jurisdiction, 
70.1 	convicted of an offense involving the distribution of products containing cannabinoids in 
70.2 	any other jurisdiction, or found liable for distributing any product that injured customers in 
70.3 	any other jurisdiction. A lower-potency hemp edible wholesaler shall disclose all relevant 
70.4 	information related to actions in another jurisdiction. Failure to disclose relevant information 
70.5 	may result in disciplinary action by the office, including the suspension, revocation, or 
70.6 	cancellation of an endorsement or license.
70.7 	(d) Notwithstanding any law to the contrary, it is not a defense in any civil or criminal 
70.8 	action that a wholesaler relied on information on a product label or otherwise provided by 
70.9 	a manufacturer who is not licensed in this state.
70.10 		Subd. 4.Products intended for sale in other jurisdictions. (a) A lower-potency hemp 
70.11 	edible wholesaler that purchases, stores, transports, or sells products containing cannabinoids 
70.12 	that do not qualify as lower-potency hemp edibles and are intended for sale only in 
70.13 	jurisdictions other than Minnesota must obtain a hemp product exporter endorsement from 
70.14 	the office.
70.15 	(b) All products containing cannabinoids that do not qualify as lower-potency hemp 
70.16 	edibles and are intended, distributed, and offered for sale only in jurisdictions other than 
70.17 	Minnesota must be physically separated from all lower-potency hemp edibles and must be 
70.18 	in packaging that clearly states that the products are not for sale in Minnesota.
70.19 	(c) All products containing cannabinoids that do not qualify as lower-potency hemp 
70.20 	edibles and are intended, distributed, and offered for sale only in jurisdictions other than 
70.21 	Minnesota must be packaged in a manner that includes verification that the product was 
70.22 	tested according to section 342.61 and that the product complies with applicable standards 
70.23 	except for any limits on the amount of any cannabinoid a product may contain. The packaging 
70.24 	must also include the product's batch number and the cannabinoid profile per serving and 
70.25 	in total.
70.26 	(d) A lower-potency hemp edible wholesaler must not sell or offer for sale products 
70.27 	containing cannabinoids that do not qualify as lower-potency hemp edibles in Minnesota 
70.28 	and must not distribute or store such products knowing or having reason to know that the 
70.29 	products will be sold in Minnesota.
70.30 	(e) The office may suspend, revoke, or cancel the license or endorsement of a 
70.31 	lower-potency hemp edible wholesaler who is prohibited from distributing products 
70.32 	containing cannabinoids in any other jurisdiction, convicted of an offense involving the 
70.33 	distribution of products containing cannabinoids in any other jurisdiction, or found liable 
70.34 	for distributing any product that injured customers in any other jurisdiction. A lower-potency 
71.1 	hemp edible wholesaler shall disclose all relevant information related to actions in another 
71.2 	jurisdiction. Failure to disclose relevant information may result in disciplinary action by 
71.3 	the office, including the suspension, revocation, or cancellation of an endorsement or license.
71.4 		Subd. 5.Transportation of lower-potency hemp edibles; endorsement. (a) A 
71.5 	lower-potency hemp edible wholesaler that transports lower-potency hemp edibles to a 
71.6 	cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, cannabis wholesaler, 
71.7 	medical cannabis combination business, different lower-potency hemp edible wholesaler, 
71.8 	or lower-potency hemp edible retailer must obtain a lower-potency hemp edible transporter 
71.9 	endorsement from the office.
71.10 	(b) In addition to the information required to be submitted under section 342.44, 
71.11 	subdivision 1, and rules adopted pursuant to that section, a person, cooperative, or business 
71.12 	seeking a lower-potency hemp edible transporter endorsement must submit the following 
71.13 	information in a form approved by the office:
71.14 	(1) an appropriate surety bond, a certificate of insurance, qualifications as a self-insurer, 
71.15 	or other securities or agreements, in the amount of not less than $300,000, for loss of or 
71.16 	damage to cargo;
71.17 	(2) an appropriate surety bond, a certificate of insurance, qualifications as a self-insurer, 
71.18 	or other securities or agreements, in the amount of not less than $1,000,000, for injury to 
71.19 	one or more persons in any one accident and, if an accident has resulted in injury to or 
71.20 	destruction of property, of not less than $100,000 because of such injury to or destruction 
71.21 	of property of others in any one accident;
71.22 	(3) the number and type of equipment the business will use to transport lower-potency 
71.23 	hemp edibles;
71.24 	(4) a loading, transporting, and unloading plan;
71.25 	(5) a description of the applicant's experience in the distribution or security business; 
71.26 	and
71.27 	(6) evidence that the business will comply with the applicable operation requirements 
71.28 	for the license being sought.
71.29 	(c) A lower-potency hemp edible wholesaler may transport lower-potency hemp edibles 
71.30 	on public roadways if:
71.31 	(1) the lower-potency hemp edibles are in a locked, safe, and secure storage compartment 
71.32 	that is part of the motor vehicle or in a locked storage container that has a separate key or 
71.33 	combination pad;
72.1 	(2) the lower-potency hemp edibles are packaged in tamper-evident containers that are 
72.2 	not visible or recognizable from outside the transporting vehicle;
72.3 	(3) the lower-potency hemp edible wholesaler has a shipping manifest in the wholesaler's 
72.4 	possession that describes the contents of all tamper-evident containers;
72.5 	(4) all departures, arrivals, and stops are appropriately documented;
72.6 	(5) no person other than a designated employee enters a vehicle at any time that the 
72.7 	vehicle is transporting lower-potency hemp edibles;
72.8 	(6) at all times that the vehicle contains lower-potency hemp edibles, the vehicle is (i) 
72.9 	secured by turning off the ignition, locking all doors and storage compartments, and removing 
72.10 	the operating keys or device, or (ii) attended by a lower-potency hemp edible wholesaler 
72.11 	employee; and
72.12 	(7) the lower-potency hemp edible wholesaler complies with any other rules adopted 
72.13 	by the office related to the transportation of lower-potency hemp edibles by a lower-potency 
72.14 	hemp edible wholesaler, except that rules requiring a lower-potency hemp edible wholesaler 
72.15 	to randomize delivery times and routes or staff vehicles with multiple employees do not 
72.16 	apply.
72.17 	(d) Any vehicle assigned for the purposes of transporting lower-potency hemp edibles 
72.18 	is subject to inspection at any time.

72.19 	EFFECTIVE DATE. This section is effective the day following final enactment.

72.20 	Sec. 22. Minnesota Statutes 2024, section 342.46, subdivision 1, is amended to read:
72.21 		Subdivision 1.Sale of lower-potency hemp edibles Authorized actions. (a) A 
72.22 	lower-potency hemp edible retailer may only sell lower-potency hemp edibles to individuals 
72.23 	who are at least 21 years of age. license, consistent with the specific license endorsement 
72.24 	or endorsements, entitles the license holder to perform any or all of the following within 
72.25 	the limits established by this section:
72.26 	(b) A lower-potency hemp edible retailer may sell lower-potency hemp edibles that:
72.27 	(1) are obtained purchase lower-potency hemp edibles from a licensed Minnesota cannabis 
72.28 	microbusiness, cannabis mezzobusiness, cannabis manufacturer, cannabis wholesaler, 
72.29 	medical cannabis combination business, or lower-potency hemp edible manufacturer, or 
72.30 	lower-potency hemp edible wholesaler; and
73.1 	(2) meet all applicable packaging and labeling requirements sell lower-potency hemp 
73.2 	edibles that meet all packaging and labeling requirements to customers who are at least 21 
73.3 	years of age;
73.4 	(3) transport and deliver lower-potency hemp edibles to customers; and
73.5 	(4) perform other actions approved by the office.

73.6 	EFFECTIVE DATE. This section is effective the day following final enactment.

73.7 	Sec. 23. Minnesota Statutes 2024, section 342.46, is amended by adding a subdivision to 
73.8 	read:
73.9 		Subd. 1a.Retailer operations endorsement. In addition to the information required to 
73.10 	be submitted under section 342.44, subdivision 1, a lower-potency hemp edible retailer that 
73.11 	intends to operate a retail establishment must indicate that intent in the form and manner 
73.12 	approved by the office.

73.13 	EFFECTIVE DATE. This section is effective the day following final enactment.

73.14 	Sec. 24. Minnesota Statutes 2024, section 342.46, is amended by adding a subdivision to 
73.15 	read:
73.16 		Subd. 1b.Delivery endorsement. (a) In addition to the information required to be 
73.17 	submitted under section 342.44, subdivision 1, a lower-potency hemp edible retailer that 
73.18 	delivers lower-potency hemp edibles must submit the following information in a form 
73.19 	approved by the office:
73.20 	(1) proof of insurance for each vehicle;
73.21 	(2) a business plan demonstrating policies to avoid sales of lower-potency hemp edibles 
73.22 	to individuals who are under 21 years of age; and
73.23 	(3) evidence that the business will comply with the applicable operation requirements 
73.24 	for the license being sought.
73.25 	(b) A lower-potency hemp edible retailer with a delivery endorsement:
73.26 	(1) must ensure that lower-potency hemp edibles are not visible from outside the delivery 
73.27 	vehicle;
73.28 	(2) must ensure that a vehicle that contains lower-potency hemp edibles is (i) secured 
73.29 	by turning off the ignition, locking all doors and storage compartments, and removing the 
74.1 	operating keys or device, or (ii) attended by a lower-potency hemp edible retailer employee; 
74.2 	and
74.3 	(3) must not use a vehicle or trailer with an image depicting the types of items being 
74.4 	transported, including but not limited to an image depicting a cannabis or hemp leaf, or a 
74.5 	name suggesting that the delivery vehicle is used for transporting lower-potency hemp 
74.6 	edibles.
74.7 	(c) Any vehicle delivering lower-potency hemp edibles is subject to inspection at any 
74.8 	time.
74.9 	(d) The office may, by policy, establish limits on the amount of lower-potency hemp 
74.10 	edibles that a single delivery vehicle may transport at any time. If the office establishes 
74.11 	limits under this paragraph, the office must notify all lower-potency hemp edible retailers 
74.12 	with a delivery endorsement of the limit and must post the limit on the office's publicly 
74.13 	accessible website.

74.14 	EFFECTIVE DATE. This section is effective the day following final enactment.

74.15 	Sec. 25. Minnesota Statutes 2024, section 342.46, subdivision 3, is amended to read:
74.16 		Subd. 3.Age verification. Prior to initiating a sale or completing a delivery, an employee 
74.17 	of the lower-potency hemp edible retailer must verify that the customer is at least 21 years 
74.18 	of age. Section 342.27, subdivision 4, applies to the verification of a customer's age.

74.19 	EFFECTIVE DATE. This section is effective the day following final enactment.

74.20 	Sec. 26. Minnesota Statutes 2024, section 342.46, subdivision 4, is amended to read:
74.21 		Subd. 4.Display and storage of lower-potency hemp edibles. A lower-potency hemp 
74.22 	edible retailer operating a retail location shall ensure that all lower-potency hemp edibles, 
74.23 	other than lower-potency hemp edibles that are intended to be consumed as a beverage, are 
74.24 	displayed behind a checkout counter where the public is not permitted or in a locked case. 
74.25 	All lower-potency hemp edibles that are not displayed must be stored in a secure area.

74.26 	EFFECTIVE DATE. This section is effective the day following final enactment.

74.27 	Sec. 27. Minnesota Statutes 2024, section 342.46, subdivision 5, is amended to read:
74.28 		Subd. 5.Transportation of lower-potency hemp edibles. (a) A lower-potency hemp 
74.29 	edible retailer may transport lower-potency hemp edibles on public roadways provided:
74.30 	(1) the lower-potency hemp edibles are in final packaging;
75.1 	(2) the lower-potency hemp edibles are packaged in tamper-evident containers that are 
75.2 	not visible or recognizable from outside the transporting vehicle;
75.3 	(3) the lower-potency hemp edible retailer has a shipping manifest in the lower-potency 
75.4 	hemp edible retailer's possession that describes the contents of all tamper-evident containers;
75.5 	(4) all departures, arrivals, and stops are appropriately documented;
75.6 	(5) no person other than a designated employee enters a vehicle at any time that the 
75.7 	vehicle is transporting lower-potency hemp edibles; and
75.8 	(6) the lower-potency hemp edible retailer complies with any other rules adopted by the 
75.9 	office, except that rules requiring a lower-potency hemp edible retailer to randomize delivery 
75.10 	times and routes or staff vehicles with multiple employees do not apply.
75.11 	(b) Any vehicle assigned for the purposes of transporting lower-potency hemp edibles 
75.12 	is subject to inspection at any time.
75.13 	(c) The requirements under paragraph (a) do not apply to the delivery of lower-potency 
75.14 	hemp edibles to customers by a lower-potency hemp edible retailer with a delivery 
75.15 	endorsement.

75.16 	EFFECTIVE DATE. This section is effective the day following final enactment.

75.17 	Sec. 28. Minnesota Statutes 2024, section 342.46, subdivision 6, is amended to read:
75.18 		Subd. 6.Compliant products. (a) A lower-potency hemp edible retailer shall ensure 
75.19 	that all lower-potency hemp edibles products containing cannabinoids offered for sale 
75.20 	qualify as hemp-derived topical products or lower-potency hemp edibles and comply with 
75.21 	the all applicable limits on the amount and types of cannabinoids that a lower-potency hemp 
75.22 	edible the product can contain, including but not limited to the requirement that lower-potency 
75.23 	hemp edibles:.
75.24 	(1) consist of servings that contain no more than five milligrams of delta-9 
75.25 	tetrahydrocannabinol, no more than 25 milligrams of cannabidiol, no more than 25 milligrams 
75.26 	of cannabigerol, or any combination of those cannabinoids that does not exceed the identified 
75.27 	amounts;
75.28 	(2) do not contain more than a combined total of 0.5 milligrams of all other cannabinoids 
75.29 	per serving; and
75.30 	(3) do not contain an artificially derived cannabinoid other than delta-9 
75.31 	tetrahydrocannabinol.
76.1 	(b) If a lower-potency hemp edible is packaged in a manner that includes more than a 
76.2 	single serving, the lower-potency hemp edible must indicate each serving by scoring, 
76.3 	wrapping, or other indicators that appear on the lower-potency hemp edible designating the 
76.4 	individual serving size. If it is not possible to indicate a single serving by scoring or use of 
76.5 	another indicator that appears on the product, the lower-potency hemp edible may not be 
76.6 	packaged in a manner that includes more than a single serving in each container, except 
76.7 	that a calibrated dropper, measuring spoon, or similar device for measuring a single serving 
76.8 	may be used for any edible cannabinoid products that are intended to be combined with 
76.9 	food or beverage products prior to consumption. If the lower-potency hemp edible is meant 
76.10 	to be consumed as a beverage, the beverage container may not contain more than two 
76.11 	servings per container.
76.12 	(c) A single package containing multiple servings of a lower-potency hemp edible must 
76.13 	contain no more than 50 milligrams of delta-9 tetrahydrocannabinol, 250 milligrams of 
76.14 	cannabidiol, 250 milligrams of cannabigerol, or any combination of those cannabinoids that 
76.15 	does not exceed the identified amounts.

76.16 	EFFECTIVE DATE. This section is effective the day following final enactment.

76.17 	Sec. 29. Minnesota Statutes 2024, section 342.46, subdivision 7, is amended to read:
76.18 		Subd. 7.Prohibitions. A lower-potency hemp edible retailer may must not:
76.19 	(1) sell or deliver lower-potency hemp edibles to an individual who is under 21 years 
76.20 	of age;
76.21 	(2) sell or deliver a lower-potency hemp edible to a person who is visibly intoxicated;
76.22 	(3) sell or deliver cannabis flower, cannabis products, or hemp-derived consumer 
76.23 	products;
76.24 	(4) allow for the dispensing of lower-potency hemp edibles in vending machines; or
76.25 	(5) distribute or allow free samples of lower-potency hemp edibles except when the 
76.26 	business is licensed to permit on-site consumption and samples are consumed within its 
76.27 	licensed premises.

76.28 	EFFECTIVE DATE. This section is effective the day following final enactment.

76.29 	Sec. 30. Minnesota Statutes 2024, section 342.46, subdivision 9, is amended to read:
76.30 		Subd. 9.Posting of notices. A lower-potency hemp edible retailer with a retail 
76.31 	endorsement must post all notices as provided in section 342.27, subdivision 6.

77.1 	EFFECTIVE DATE. This section is effective the day following final enactment.

77.2 	Sec. 31. Minnesota Statutes 2024, section 342.62, subdivision 2, is amended to read:
77.3 		Subd. 2.Packaging requirements. (a) Except as provided in paragraph (b), all cannabis 
77.4 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer products 
77.5 	sold to customers or patients must be:
77.6 	(1) prepackaged in packaging or a container that is child-resistant, tamper-evident, and 
77.7 	opaque; or
77.8 	(2) placed in packaging or a container that is plain, child-resistant, tamper-evident, and 
77.9 	opaque at the final point of sale to a customer.
77.10 	(b) The requirement that packaging be child-resistant does not apply to a lower-potency 
77.11 	hemp edible that is intended to be consumed as a beverage.
77.12 	(c) If a cannabis product, lower-potency hemp edible, or a hemp-derived consumer 
77.13 	product is packaged in a manner that includes more than a single serving, each serving must 
77.14 	be indicated by scoring, wrapping, or other indicators designating the individual serving 
77.15 	size. If the item is a lower-potency hemp edible, serving indicators must meet the 
77.16 	requirements of section 342.46, subdivision 6, paragraph (b).
77.17 	(d) Notwithstanding paragraph (c), any edible cannabinoid products that are intended 
77.18 	to be combined with food or beverage products before consumption must indicate a single 
77.19 	serving using one of the following methods:
77.20 	(1) the product is packaged in individual servings;
77.21 	(2) the product indicates a single serving by scoring or use of another indicator that 
77.22 	appears on the product; or
77.23 	(3) the product is sold with a calibrated dropper, measuring spoon, or similar device for 
77.24 	measuring a single serving.
77.25 	(e) A package containing multiple servings of a lower-potency hemp edible that is not 
77.26 	intended to be consumed as a beverage must not contain:
77.27 	(1) more than 50 milligrams of delta-9 tetrahydrocannabinol;
77.28 	(2) more than 1,000 milligrams of cannabidiol, cannabigerol, cannabinol, or 
77.29 	cannabichromene:
77.30 	(3) more than the established limit of any other cannabinoid authorized by the office; 
77.31 	or
78.1 	(4) any combination of those cannabinoids that exceeds the identified amounts for the 
78.2 	applicable product category.
78.3 	(f) A single container containing a lower-potency hemp edible product that is intended 
78.4 	to be consumed as a beverage must not contain:
78.5 	(1) more than ten milligrams of delta-9 tetrahydrocannabinol;
78.6 	(2) more than 200 milligrams of cannabidiol, cannabigerol, cannabinol, or 
78.7 	cannabichromene;
78.8 	(3) more than the established limit of any other cannabinoid authorized by the office; 
78.9 	or
78.10 	(4) any combination of those cannabinoids that exceeds the identified amounts for the 
78.11 	applicable product category.
78.12 	(d) (g) Edible cannabis products and lower-potency hemp edibles containing more than 
78.13 	a single serving must be prepackaged or placed at the final point of sale in packaging or a 
78.14 	container that is resealable.

78.15 	EFFECTIVE DATE. This section is effective the day following final enactment.

78.16 	Sec. 32. Minnesota Statutes 2024, section 342.63, subdivision 5, is amended to read:
78.17 		Subd. 5.Content of label; hemp-derived topical products. (a) All hemp-derived topical 
78.18 	products sold to customers must have affixed to the packaging or container of the product 
78.19 	a label that contains at least the following information:
78.20 	(1) the manufacturer name, location, phone number, and website;
78.21 	(2) the name and address of the independent, accredited laboratory used by the 
78.22 	manufacturer to test the product;
78.23 	(3) the net weight or volume of the product in the package or container;
78.24 	(4) the type of topical product;
78.25 	(5) the amount or percentage of cannabidiol, cannabigerol, or any other cannabinoid, 
78.26 	derivative, or extract of hemp, per serving and in total;
78.27 	(6) a list of ingredients;
78.28 	(7) a statement that the product does not claim to diagnose, treat, cure, or prevent any 
78.29 	disease and that the product has not been evaluated or approved by the United States Food 
78.30 	and Drug Administration, unless the product has been so approved; and
79.1 	(8) any other statements or information required by the office.
79.2 	(b) The information required in paragraph (a), clauses (1), (2), and (5), may be provided 
79.3 	through the use of a scannable barcode or matrix barcode that links to a page on a website 
79.4 	maintained by the manufacturer or distributor if that page contains all of the information 
79.5 	required by this subdivision.

79.6 	Sec. 33. Minnesota Statutes 2024, section 342.66, subdivision 6, is amended to read:
79.7 		Subd. 6.Prohibitions. (a) A product sold to consumers under this section must not be 
79.8 	manufactured, marketed, distributed, or intended:
79.9 	(1) for external or internal use in the diagnosis, cure, mitigation, treatment, or prevention 
79.10 	of disease in humans or other animals;
79.11 	(2) to affect the structure or any function of the bodies of humans or other animals;
79.12 	(3) to be consumed by combustion or vaporization of the product and inhalation of 
79.13 	smoke, aerosol, or vapor from the product;
79.14 	(4) to be consumed through chewing; or
79.15 	(5) to be consumed through injection or application to nonintact skin or a mucous 
79.16 	membrane or nonintact skin, except for products applied sublingually.
79.17 	(b) A product manufactured, marketed, distributed, or sold to consumers under this 
79.18 	section must not:
79.19 	(1) consist, in whole or in part, of any filthy, putrid, or decomposed substance;
79.20 	(2) have been produced, prepared, packed, or held under unsanitary conditions where 
79.21 	the product may have been rendered injurious to health, or where the product may have 
79.22 	been contaminated with filth;
79.23 	(3) be packaged in a container that is composed, in whole or in part, of any poisonous 
79.24 	or deleterious substance that may render the contents injurious to health;
79.25 	(4) contain any additives or excipients that have been found by the United States Food 
79.26 	and Drug Administration to be unsafe for human or animal consumption;
79.27 	(5) contain a cannabinoid or an amount or percentage of cannabinoids that is different 
79.28 	than the information stated on the label;
79.29 	(6) contain a cannabinoid, other than cannabidiol, cannabigerol, or a cannabinoid 
79.30 	approved by the office, in an amount that exceeds the standard established in subdivision 
79.31 	2 3, paragraph (c); or
80.1 	(7) contain any contaminants for which testing is required by the office in amounts that 
80.2 	exceed the acceptable minimum standards established by the office.
80.3 	(c) No product containing any cannabinoid may be sold to any individual who is under 
80.4 	21 years of age.

	ARTICLE 1	MEDICAL CANNABIS........	Page.Ln 1.26	
	ARTICLE 2	CANNABIS BUSINESS LICENSING AND OPERATIONS........	Page.Ln 31.18	
	ARTICLE 3	HEMP BUSINESS REGULATIONS........	Page.Ln 51.8	

APPENDIX 

Repealed Minnesota Statutes: UES2370-1 

152.22 DEFINITIONS.Subd. 2.Commissioner. 
"Commissioner" means the commissioner of health. 

342.151 EMPLOYEES OF LICENSE HOLDERS.Subdivision 1.Definitions. 
For purposes of this section, a "license holder" includes a cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis manufacturer, cannabis retailer, cannabis wholesaler, cannabis transporter, cannabis testing facility, cannabis event organizer, cannabis delivery service, lower-potency hemp edible manufacturer, lower-potency hemp edible retailer, or medical cannabis combination business. 

342.36 CANNABIS TRANSPORTER OPERATIONS.Subd. 5.Randomized deliveries. 
A cannabis transporter shall ensure that all delivery times and routes are randomized.